Medicare Program; Establishing Additional Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Supplier Enrollment Safeguards, 52629-52649 [2010-21354]
Download as PDF
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Part 424
[CMS–6036–F]
RIN 0938–AO90
Medicare Program; Establishing
Additional Medicare Durable Medical
Equipment, Prosthetics, Orthotics, and
Supplies (DMEPOS) Supplier
Enrollment Safeguards
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final rule.
AGENCY:
This final rule will clarify,
expand, and add to the existing
enrollment requirements that Durable
Medical Equipment and Prosthetics,
Orthotics, and Supplies (DMEPOS)
suppliers must meet to establish and
maintain billing privileges in the
Medicare program.
DATES: These regulations are effective
on September 27, 2010.
FOR FURTHER INFORMATION CONTACT:
Barry Bromberg, (410) 786–9953 for
general issues, on-site inspections,
maintaining ordering and referring
documentation, and hours of operation.
Kimberly McPhillips, (410) 786–5374
for issues related to compliance with
applicable laws, appropriate sites, direct
solicitation, oxygen suppliers, and
prohibition on sharing a practice
location.
SUPPLEMENTARY INFORMATION:
SUMMARY:
WReier-Aviles on DSKGBLS3C1PROD with RULES
I. Background
A. General Overview
Medicare services are furnished by
two types of entities, providers, and
suppliers. At § 400.202, the term
‘‘provider’’ is defined as a hospital, a
critical access hospital (CAH), a skilled
nursing facility (SNF), a comprehensive
outpatient rehabilitation facility (CORF),
a home health agency (HHA), or a
hospice that has in effect an agreement
to participate in Medicare, or a clinic, a
rehabilitation agency, or a public health
agency that has in effect a similar
agreement but only to furnish outpatient
physical therapy or speech pathology
services, or a community mental health
center that has in effect a similar
agreement but only to furnish partial
hospitalization services. The term
‘‘provider’’ is also defined in sections
1861(u) and 1866(e) of the Social
Security Act (the Act).
For purposes of the DMEPOS supplier
standards, the term ‘‘supplier’’ is defined
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
in § 424.57(a) as an entity or individual,
including a physician or Part A
provider, that sells or rents Part B
covered DMEPOS items to Medicare
beneficiaries that meet the DMEPOS
supplier standards. This final rule
applies to all DMEPOS suppliers and
amends the DMEPOS supplier standards
set forth at § 424.57(c). Those
individuals or entities that do not
furnish DMEPOS items but furnish
other types of health care services only
(for example, physician services or
nurse practitioner services) would not
be subject to this requirement. A
supplier that furnishes durable medical
equipment, prosthetics, orthotics, and
suppliers (DMEPOS) is one category of
supplier. Other supplier categories may
include, for example, physicians, nurse
practitioners, and physical therapists. If
a supplier, such as a physician or
physical therapist, also provides
DMEPOS to a patient, then the supplier
is also considered to be a DMEPOS
supplier. The term ‘‘DMEPOS’’
encompasses the types of items
included in the definition of medical
equipment and supplies in section
1834(j)(5) of the Act.
In FY 2007, the Medicare program
spent more than $10 billion for
DMEPOS supplies, and in March 2008,
there were 113,154 individual DMEPOS
suppliers. However, due to the
affiliation of some DMEPOS suppliers
with chains, there were 65,984 unique
billing numbers. The largest
concentrations of DMEPOS suppliers
were located in five States: California
(approximately 9 percent), Texas
(approximately 7 percent), Florida
(approximately 7 percent), New York
(approximately 6 percent) and
Pennsylvania (approximately 5 percent).
We believe that approximately 20
percent of the DMEPOS suppliers are
located in rural areas throughout the
United States and that the vast majority
of DMEPOS suppliers are small entities
(based on Medicare reimbursement
alone).
The term ‘‘durable medical
equipment’’ is defined at section 1861(n)
of the Act. This definition, in part,
excludes from coverage as DMEPOS,
items furnished in SNFs and hospitals.
Also, the term DMEPOS is included in
the definition of ‘‘medical and other
health services’’ in section 1861(s)(6) of
the Act. Furthermore, the term is
defined in § 414.202 as equipment
furnished by a supplier or a HHA that—
• Can withstand repeated use;
• Is primarily and customarily used
to serve a medical purpose;
• Generally is not useful to an
individual in the absence of an illness
or injury; and
PO 00000
Frm 00023
Fmt 4700
Sfmt 4700
52629
• Is for use in the home.
Examples of DMEPOS supplies include
items such as blood glucose monitors,
hospital beds, nebulizers, oxygen
delivery systems, and wheelchairs.
Prosthetic devices are included in the
definition of ‘‘medical and other health
services’’ under section 1861(s)(8) of the
Act. Prosthetic devices are defined in
this section of the Act as ‘‘devices (other
than dental) which replace all or part of
an internal body organ (including
colostomy bags and supplies directly
related to colostomy care), including
replacement of such devices, and
including one pair of conventional
eyeglasses or contact lenses furnished
subsequent to each cataract surgery with
insertion of an intraocular lens.’’ Other
examples of prosthetic devices include
cardiac pacemakers, cochlear implants,
electrical continence aids, electrical
nerve stimulators, and tracheostomy
speaking valves.
Section 1861(s)(9) of the Act provides
for the coverage of ‘‘leg, arm, back, and
neck braces, and artificial legs, arms,
and eyes, including replacement of
required because of a change in the
patient’s physical condition.’’ As
indicated by section 1834(h)(4)(C) of the
Act, these items are often referred to as
‘‘orthotics and prosthetics.’’ Under
section 1834(h)(4)(B) of the Act,
prosthetic devices do not include
parenteral and enteral nutrition
nutrients and implantable items payable
under section 1833(t) of the Act.’’
Section 1861(s)(5) of the Act includes
‘‘surgical dressings, splints, casts, and
other devices used for reduction of
fractures and dislocation’’ as one of the
‘‘medical and other health services’’ that
is covered by Medicare. Other items that
may be furnished by suppliers would
include (among others):
• Prescription drugs used in
immunosuppressive therapy furnished
to an individual who receives an organ
transplant for which payment is made
under this title, and that are furnished
within a certain time period after the
date of the transplant procedure as
noted at section 1861(s)(2)(j) of the Act.
• Extra-depth shoes with inserts or
custom molded shoes with inserts for an
individual with diabetes as listed at
section 1861(s)(12) of the Act.
• Home dialysis supplies and
equipment, self-care home dialysis
support services, and institutional
dialysis services and supplies included
at section 1861(s)(2)(F) of the Act.
• Oral drugs prescribed for use as an
anticancer therapeutic agent as specified
in section 1861(s)(2)(Q) of the Act.
• Self-administered erythropoietin as
described in section 1861(s)(2)(O) of the
Act.
E:\FR\FM\27AUR1.SGM
27AUR1
52630
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
WReier-Aviles on DSKGBLS3C1PROD with RULES
The National Supplier Clearinghouse
(NSC) is the Center for Medicare &
Medicaid Services’ (CMS) designated
national enrollment contractor for
DMEPOS suppliers. The primary
functions of the NSC are to: (1) Ensure
that only qualified suppliers of
DMEPOS are enrolled or remain
enrolled in the Medicare program;
(2) process enrollment application in
timely and accurate manner; and
(3) take the necessary actions to revoke
enrolled suppliers who no longer meet
supplier standards.
B. Statutory Authority
Various sections of the Act and the
regulations require providers and
suppliers to furnish information
concerning the amounts due and the
identification of individuals or entities
that furnish medical services to
beneficiaries before payment can be
made. The following is an overview of
the sections that grant this authority:
• Sections 1102 and 1871 of the Act
provide general authority for the
Secretary of Health and Human Services
(the Secretary) to prescribe regulations
for the efficient administration of the
Medicare program. Under this authority,
this final rule will require the collection
of information from providers and
suppliers for the purpose of enrolling in
the Medicare program and granting
privileges to bill the program for health
care services furnished to Medicare
beneficiaries.
• Sections 1814(a), 1815(a), and
1833(e) of the Act require the
submission of information necessary to
determine the amounts due a provider
or other person.
• Section 1834(j)(1)(A) of the Act
states that no payment may be made for
items furnished by a supplier of medical
equipment and supplies unless such
supplier obtains (and renews at such
intervals as the Secretary may require)
a supplier number. In order to obtain a
supplier billing number, a supplier must
comply with certain supplier standards
as identified by the Secretary.
• Section 1842(r) of the Act requires
CMS to establish a system for furnishing
a unique identifier for each physician
who furnishes services for which
payment may be made. To complete
this, we need to collect information
unique to that physician.
• Section 1862(e)(1) of the Act states
that no payment may be made when an
item or service was at the medical
direction of an individual or entity that
is excluded in accordance with sections
1128, 1128A, 1156, or 1842(j)(2) of the
Act.
• Section 4312 of the Balanced
Budget Act of 1997 (BBA) (Pub. L. 105–
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
33) amended section 1834 of the Act to
require that certain Medicare supplies of
durable medical equipment, prosthetics,
and supplies (DMEPOS) to furnish CMS
with a surety bond in an amount not
less than $50,000.
• Section 4313 of the BBA amended
sections 1124(a)(1) and 1124A of the Act
to require disclosure of both the
Employer Identification Number (EIN)
and Social Security Number (SSN) of
each provider or supplier, each person
with ownership or control interest in
the provider or supplier, any
subcontractor in which the provider or
supplier directly or indirectly has a 5
percent or more ownership interest, and
any managing employees including
Directors and Board Members of
corporations and non-profit
organizations and charities. The ‘‘Report
to Congress on Steps Taken to Assure
Confidentiality of Social Security
Account Numbers as Required by the
Balanced Budget Act’’ was signed by the
Secretary and sent to the Congress on
January 26, 1999. This report outlines
the provisions of a mandatory collection
of SSNs and EINs effective on or after
April 26, 1999.
• Section 31001(i)(1) of the Debt
Collection Improvement Act of 1996
(DCIA) (Pub. L. 104–134) amended
section 7701 of 31 U.S.C. by adding
paragraph (c) to require that any person
or entity doing business with the
Federal Government must provide their
Tax Identification Number (TIN).
• Section 936(a) of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173) amended section 1866 of
the Act by adding a new subsection
(j)(1) to require the Secretary to establish
a process for the enrollment of providers
of services and suppliers.
• Section 302(a)(1) of MMA amended
the Act to require the Secretary to
develop quality standards for DMEPOS
suppliers.
• Section 154(b) of the MIPPA
amended the Act to establish a deadline
for DMEPOS accreditation.
Section 6405(a) of the Affordable Care
Act (ACA) requires that in order for
payment for services to be made, a
physician who orders DME for
individuals must be a Medicare
participating physician enrolled under
section 1866(j) of the Act or an eligible
professional under section 1848(k)(3)(B)
of the Act that is enrolled under section
1866(j) of the Act.
We are authorized to collect
information on the Medicare enrollment
application (that is, the CMS–855,
(Office of Management and Budget
(OMB) approval number 0938–0685)) to
ensure that correct payments are made
PO 00000
Frm 00024
Fmt 4700
Sfmt 4700
to providers and suppliers under the
Medicare program as established by
Title XVIII of the Act.
II. Provisions of the Proposed Rule
In the January 25, 2008 Federal
Register (73 FR 4503), we published a
proposed rule that clarified, revised,
and added to the DMEPOS supplier
standards in § 424.57.
In § 424.57(c)(1), we proposed to
revise this supplier standard by adding
language to clarify that a DMEPOS
supplier must be licensed to provide
licensed service(s) and cannot contract
with an individual or entity to provide
the licensed service(s).
The purpose of this standard is to
ensure that DMEPOS suppliers obtain
and maintain the necessary State
licenses required to furnish the services
provided to Medicare beneficiaries. In
addition, we believe that each DMEPOS
supplier is responsible for determining
what licenses are required to operate a
DMEPOS supplier’s business. While the
NSC maintains information regarding
State licensure laws, we do not believe
that the NSC is responsible for notifying
any supplier of what licenses are
required or that any changes have
occurred in the State licensing
requirements. We believe that we are
enrolling DMEPOS suppliers, not third
party agents that subcontract their
operations to suppliers that are not
enrolled or cannot enroll in the
Medicare program. Therefore, to ensure
that only qualified suppliers are
enrolled or maintain enrollment in the
Medicare program, we maintain that a
DMEPOS supplier must be licensed to
provide licensed service(s) and cannot
contract with an individual or entity to
provide the licensed service(s).
In § 424.57(c)(7), we proposed to
clarify the supplier standard for
maintaining a physical facility on an
appropriate site. Specially, we proposed
to clarify the term, ‘‘appropriate site.’’ In
addition, we stated that an ‘‘appropriate
site’’ applies to ‘‘closed door’’ businesses,
(such as pharmacies/suppliers
providing services only to beneficiaries
residing in a nursing home). We also
solicited comments on whether we
should establish a minimum square
footage requirement to the definition of
an appropriate site and what, if any,
appropriate exceptions would apply to
a minimum square footage requirement.
The supplier location must be
accessible during posted business hours
to beneficiaries and to CMS, and must
maintain a visible sign and posted hours
of operation. We believe that all
DMEPOS suppliers must have a
permanent, durable sign that is visible
at the main entrance of the facility and
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
positioned so that it is visible to the
public, including customers using
wheelchairs.
In § 424.57(c)(8), we proposed to
clarify this provision by revising (c)(8)
to read as follows: ‘‘Permits CMS, the
NSC, or agents of CMS or the NSC to
conduct on-site inspections to ascertain
supplier compliance with the
requirements of this section.’’ If the NSC
or its agents are unable to perform a site
visit during a supplier’s posted business
hours, the NSC would deny billing
privileges for prospective applicants or
would revoke the billing privileges of
DMEPOS suppliers enrolled in the
Medicare program.
In § 424.57(c)(9), we proposed to
revise this supplier standard to exclude
the use of cell phones and beepers/
pagers as a method of receiving calls or
using ‘‘call forwarding’’ to forward a call
to a cell phone or beeper/pager from the
public or beneficiaries during the
supplier’s posted hours of operation. We
maintain that DMEPOS suppliers who
are utilizing cell phones, call
forwarding, beeper numbers, pagers,
answering services or other methods to
receive telephone calls in a location
other than the place of business for
business calls during their posted hours
of operations are not in compliance with
this standard and that DMEPOS
suppliers who exclusively use
answering machines or answering
services during their posted hours of
operations are not in compliance with
this standard. Therefore, we revised this
standard to read, ‘‘Maintains a primary
business telephone that is operating at
the appropriate site listed under the
name of the business locally or toll-free
for beneficiaries. The use of cellular
phones, beeper numbers, and pagers as
the primary business phone is
prohibited. Additionally, DMEPOS
suppliers are prohibited from
forwarding calls from the primary
business telephone listed under the
name of the business to a cellular
phone, or a beeper/pager. The exclusive
use of answering machines, answering
services or facsimile machine (or
combination of these options) cannot be
used as the primary business telephone
during posted operating hours.’’
In § 424.57(c)(10), we proposed to
revise this provision to specify that the
DMEPOS supplier has a comprehensive
liability insurance policy in the amount
of at least $300,000 per incident that
covers both the supplier’s place of
business and all customers and
employees of the supplier and ensures
that insurance policy must remain in
force at all times. In addition, we
proposed that a DMEPOS supplier must
list the NSC as a certificate holder on
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
the policy and notify the NSC in writing
within 30 days of any policy changes or
cancellations.
In § 424.57(c)(11), we proposed to
revise this supplier standard to clarify
that suppliers cannot directly solicit
patients, which includes, but is not
limited to, a prohibition on telephone,
computer e-mail or instant messaging,
coercive response Internet advertising
on sites unrelated to DMEPOS products,
or in-person contacts. We also proposed
that DMEPOS supplier may only contact
the Medicare beneficiary under the
current provisions at § 424.57(c)(11)(i)
through (iii). We believe that if CMS or
the NSC through on-site inspection
obtains or develops evidence that a
DMEPOS supplier has made prohibited
contacts with Medicare beneficiaries in
violation of the provisions found in this
section that CMS or the NSC may revoke
that supplier’s billing privileges, and
may determine if such billing may be for
fraudulent or unnecessary supplies.
In § 424.57(c)(12), we proposed to
revise the provision to clarify its intent.
Specifically, we proposed that a
DMEPOS supplier: (1) Is responsible for
maintaining proof of the delivery in the
beneficiary’s file; (2) must furnish
information to beneficiaries at the time
of delivery of items as to how the
beneficiary can contact the supplier by
telephone; (3) must provide the
beneficiary with instructions on how to
safely and effectively use the equipment
or contract this service to a qualified
individual; (4) is responsible for
providing instruction on the safe and
effective use of the equipment that
should be completed at the time of
delivery; and (5) must document that
this instruction has taken place. Our
proposal was based on the belief that a
DMEPOS supplier is solely responsible
for delivery of Medicare-covered items
and for instruction on the use of those
items. While we believe that a DMEPOS
supplier may choose to contract out the
delivery of Medicare-covered items to
another individual or entity, the
DMEPOS supplier has ultimate
responsibility for ensuring delivery in
accordance with this standard and for
maintaining all necessary
documentation to demonstrate that the
beneficiary received the Medicarecovered item and appropriate
instructions for its use. We believe that
our revised interpretation of this section
will help to ensure that instructions for
the safe and appropriate use of products
will be given to beneficiaries.
In § 424.57(c)(27), we proposed a new
standard that specified that the
DMEPOS supplier must obtain oxygen
from a State-licensed oxygen supplier.
To ensure that DMEPOS suppliers meet
PO 00000
Frm 00025
Fmt 4700
Sfmt 4700
52631
and maintain this standard, we believe
that DMEPOS suppliers who are
supplying oxygen must contract with a
supplier licensed by the State to provide
them with oxygen. Obviously, this
standard does not apply when the State
does not license oxygen suppliers. We
understand that in certain areas,
DMEPOS suppliers may obtain oxygen
from oxygen suppliers in other States.
However, when a DMEPOS supplier is
located in a State where licensure is
required, then they must obtain their
oxygen from a State-licensed oxygen
supplier, regardless of which State the
oxygen supplier obtained their
licensure. We believe that this standard
would help to protect Medicare
beneficiaries and promote quality in the
furnishing of oxygen.
In § 424.57(c)(28), we proposed a new
supplier standard that states that the
supplier is required to maintain
ordering and referring documentation,
including the National Provider
Identifier, received from a physician,
nurse practitioner, physician assistant,
clinical social worker, or certified nurse
midwife, for 7 years after the claim has
been paid. We maintain that a DMEPOS
supplier should retain the necessary
ordering and referring documentation
received from physicians, nurse
practitioners, physician assistants,
clinical social workers, or certified
nurse midwives to assure themselves
that coverage criterion for an item has
been met. If the information in the
patient’s medical record does not
adequately support the medical
necessity for the item, the supplier is
liable for the dollar amount involved
unless a properly executed Advance
Beneficiary Notice of possible denial
has been obtained.
In § 424.57(c)(29), we proposed a new
standard that specifies that the supplier
is prohibited from sharing a practice
location with another Medicare
supplier. In addition, we solicited
comments on whether we should
establish an exception to this space
sharing proposal for physicians and
nonphysician practitioners and the
circumstances which warrant an
exception since we are aware that
physicians and other licensed
nonphysician practitioners may obtain
their own DMEPOS supplier number
and furnish DMEPOS from their office.
We believe that allowing a DMEPOS
supplier to commingle its practice
location with another DMEPOS supplier
effectively limits the ability of CMS and
the NSC to ensure that each DMEPOS
supplier meets all of the supplier
standards specified at § 424.57. Since
we are aware that physicians and other
licensed nonphysician practitioners
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
52632
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
may obtain their own DMEPOS supplier
number and furnish DMEPOS from their
office, we solicited comments on
whether we should establish an
exception to this space sharing proposal
for physicians and nonphysician
practitioners and the circumstances
which warrant an exception.
In § 424.57(c)(30), we proposed a new
supplier standard that would require a
DMEPOS supplier to be open to the
public a minimum of 30 hours per
week, except for those DMEPOS
suppliers who are working with custommade or fitted orthotics and prosthetics.
We believe that most legitimate
DMEPOS suppliers are open to the
public for more than 40 hours per week
and that all legitimate DMEPOS would
need to be open a minimum of at least
30 hours per week in order to attract,
retain, and serve Medicare beneficiaries.
Given that Medicare beneficiaries may
not be able to find transportation during
limited operating hours, the DMEPOS
supplier must be open and available for
periods long enough for beneficiaries to
readily access their facility. We believe
that most legitimate DMEPOS suppliers
are open to the public for more than 40
hours per week and that all legitimate
DMEPOS would need to be open a
minimum of at least 30 hours per week
in order to attract, retain, and serve
Medicare beneficiaries. To ensure that
DMEPOS suppliers are able to report
any change in their posted business
hours, we are proposing to revise the
CMS–855S Medicare enrollment
application to accommodate this
proposed change.
In § 424.57(c)(31), we proposed to add
a new supplier standard that specified
that a DMEPOS supplier could not have
Internal Revenue Service (IRS) or a State
taxing authority tax delinquency. We
also proposed to define a ‘‘tax
delinquency’’ as meaning an amount of
money owed to the United States or a
State: a conviction or civil judgment for
tax evasion, a criminal or civil charge of
tax evasion, or the filing of a tax lien.
In § 424.57(d), we proposed to
redesignate the current text as paragraph
(d)(1) and proposed adding a new
paragraph that specified that ‘‘CMS, the
NSC, or CMS designated contractor
establishes a Medicare overpayment
from the date of an adverse legal action
or felony conviction (including felony
convictions within the 10 years
preceding enrollment or revalidation of
enrollment) that precludes payment. In
addition, we proposed that any
overpayment assessed by CMS or its
designated contractor due to a lack of
reporting would follow the existing
rules governing Medicare overpayments
set forth at § 405.350 et seq. We believe
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
that § 424.57(d)(2) is necessary because
some DMEPOS suppliers fail to report
adverse legal actions and felony
convictions to the NSC within the 30
days of the reportable event. Since it is
essential that DMEPOS suppliers notify
the NSC of all adverse legal actions and
felony convictions within 30 days of the
reportable event, we believe that it is
essential to establish this new provision.
This new provision would allow the
CMS, the NSC, or a designated Medicare
contractor the authority to assess and
collect an overpayment from the time of
the reportable event. In addition, the
CMS, the NSC, or a designated CMS
contractor would revoke the DMEPOS
supplier’s Medicare billing privileges, in
accordance with § 424.57(d)(1), if the
legal adverse action or felony conviction
precludes participation in or payment
from the Medicare program.
III. Analysis of and Responses to Public
Comments
In the January 25, 2008 Federal
Register (73 FR 4503), we published a
proposed rule that clarified, revised,
and added to the DMEPOS supplier
standards in § 424.57.
We received 208 timely comments in
response to the proposed rule. In this
section of the final rule we present a
summary of our proposals and address
the comments received on these
proposals.
A. Clarifications and Revisions of
Existing DMEPOS Supplier Standards
1. Licensure Requirements
In § 424.57(c)(1), we proposed to
revise this supplier standard by adding
language to clarify that a DMEPOS
supplier must be licensed to provide
licensed service(s) and cannot contract
with an individual or entity to provide
the licensed service(s). These licensed
services include but are not limited to
supplying oxygen or a general DMEPOS
license.
Comment: A commenter believes the
NSC should maintain and make
available, a list of each State’s licensing
requirements.
Response: The National Supplier
Clearinghouse (NSC) does maintain
information regarding State licensure
laws for DMEPOS suppliers on its Web
site (see https://www.palmettogba.com/
nsc). However, the DMEPOS supplier is
ultimately responsible for determining
what business, product and other
applicable licenses are required for his
or her business, regardless of the
accuracy of the information provided on
the NSC Web site. We also believe it is
the business owner’s responsibility to be
aware of any changes in the State
PO 00000
Frm 00026
Fmt 4700
Sfmt 4700
licensing requirements for his or her
business. During the enrollment and
reenrollment process the NSC verifies
that the DMEPOS supplier is in
compliance with all applicable State
licensing requirements.
Comment: Several commenters
supported requiring DMEPOS suppliers
to be licensed for all services they
provide and that DMEPOS suppliers
should not be allowed to contract out
for these services. In addition, one
commenter stated that the changes
proposed to the licensure requirement
for Medicare suppliers are necessary
and beneficial.
Response: We agree and are revising
§ 424.57(c)(1)(ii)(C) to address the
commenters’ concern regarding
contracting out of services. In addition,
this requirement applies to the
competitive bidding program as
governed by part 414, subpart F.
Comment: A commenter believes that
because of the complexity of State
licensing requirements, it is too severe
to revoke all billing numbers when
licensing requirements are not met in
only one State.
Response: We do not believe that
there are any exceptions to State
licensing requirements, unless the State
in which the DMEPOS supplier
furnishes services provides for such an
exception, and that exception does not
conflict with Federal law. Moreover,
while a DMEPOS supplier can enroll
using a single tax identification number
(TIN) for one or more practice locations,
a DMEPOS supplier also may obtain
different TINs for each practice location.
If the DMEPOS supplier makes the
business decision to enroll multiple
practice locations under the same TIN,
a revocation by the NSC of this TIN will
necessitate the revocation of related
businesses associated with that TIN.
Comment: One commenter stated that
restricting licensed professionals to W–
2 employees likely will increase overall
operating expenses and requested that
we clarify that licensed professionals
may be hired as either part-time or fulltime employees.
Response: We agree and have revised
§ 424.57(c)(1)(ii) to clarify that the
licensed professionals must be part-time
or full-time employees.
Comment: A commenter stated that
§ 424.57(c)(1)(ii) as written, would allow
DMEPOS suppliers to contract with
nonlicensed individuals to avoid
contracting with licensed individuals.
In addition, it would not be financially
feasible for all DMEPOS suppliers to
have licensed professionals on staff, and
therefore, CMS should allow contracting
for services as long as they are in
compliance with State requirements.
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
Response: We do not believe that this
provision is written in such a way as to
allow DMEPOS suppliers to contract
with nonlicensed individuals to avoid
employing part-time or full-time W–2
employees. In addition, we believe that
a DMEPOS supplier who does not have
a licensed individual on staff (part-time
or full-time) as a W–2 employee would
be in violation of § 424.57(c)(1).
Moreover, while we are concerned with
the financial burden placed on small
businesses, we recognize that a certain
amount of capital is required to
establish and maintain a business. To
this end, we believe that enrolled
DMEPOS suppliers should be required
to meet State licensing qualifications,
rather than subcontracting to a thirdparty agent who may or may not be
qualified. Moreover, since we cannot
ensure with any degree of certainty, the
qualifications of a subcontracted
individual or his or her compliance
with Federal, State, and local licensure
requirements, we believe the Medicare
program and its Medicare beneficiaries
would be better served if we could
verify that a DMEPOS supplier meets
the applicable State licensing
requirements for a DMEPOS supplier’s
chosen specialty.
Comment: One commenter questioned
whether CMS considers a coemployment arrangement with a
Professional Employment Organization
to be compliant or noncompliant with
this proposed rule.
Response: We would consider a coemployment arrangement with a
professional employment organization
to be compliant with this proposed rule
provided any licensed services are
performed by an individual who
receives a W–2 with the DMEPOS
supplier’s legal business name on it. For
situations of co-employment, the W–2
also may have the legal business name
of the professional employment
organization, but this must be in
addition to the DMEPOS supplier’s legal
business name.
Comment: A commenter requested
that physical therapy clinics be exempt
from the requirement for State
certification that applies to DMEPOS
suppliers because it will affect patient
access to necessary care if the physical
therapy clinic in which an individual
was being treated was not certified as a
DMEPOS supplier and that it is an
unnecessary burden to apply the same
rules to licensed health care
professionals as supplier companies.
Response: We believe that enrolled
DMEPOS suppliers should meet all
applicable State licensing requirements.
We do not believe it is an unnecessary
burden to apply the same rules to
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
licensed health care professionals as
supplier companies; in fact, to do
otherwise would allow different
regulatory and compliance standards to
emerge. Finally, many of the rules of
licensed health care professionals and
many of the rules of the supplier
companies are not duplicative or
consecutive; rather, they are cumulative.
Comment: Several commenters
believe that the licensing requirement
provision is too restrictive and should
be revised to state that properly licensed
personnel are available to furnish the
offered services. In addition, these
commenters stated that the current
language is too broad and would
include administrative staff.
Response: This final regulation states
that a DMEPOS supplier must be in
compliance with Federal, State, and
local laws and requirements. It also
states a DMEPOS supplier cannot
contract with an individual or other
entity to provide licensed services. This
requirement only would apply to a
DMEPOS supplier’s administrative staff
if the administrative staff member is
also responsible for providing a licensed
service for the DMEPOS supplier.
Moreover, we are promoting a State’s
prerogatives on licensure by imposing
this requirement only in States where
there are no such rules for contracting
for licensed services. Rather, we are
hoping to diminish the chance of
fraudulent practices by requiring that a
DMEPOS supplier directly furnish
licensed services.
Comment: One commenter believes
disallowing contracting with
individuals or entities is unfair to the
small supplier.
Response: While we are concerned
with the potential financial burden that
this change imposes on small
businesses, and we will monitor the
impact of this requirement on small
businesses. We believe that small
DMEPOS suppliers should meet the
applicable State licensing requirements
for the services they provide.
Comment: One commenter
recommended that rather than
restricting the practice of contracting
with licensed personnel, CMS should
require the supplier to purchase
additional insurance to cover the
licensed person.
Response: We believe that a DMEPOS
supplier must meet the applicable State
licensing requirements for the services
they provide to Medicare beneficiaries.
In addition, while we agree that
additional insurance may provide
additional protection for the supplier, it
does not help to ensure that a Medicare
beneficiary is receiving quality products
and instruction from a licensed
PO 00000
Frm 00027
Fmt 4700
Sfmt 4700
52633
individual and we will allow
contracting for licensed services only
when the State where the item or
service is supplied permits a DMEPOS
supplier to contract for licensed
services. Moreover, we believe that
DMEPOS suppliers participating in
competitive bidding must maintain all
applicable State licenses for the
products and services they are bidding
on or furnishing in each competitive
bidding area. In addition, we believe
that it is the responsibility of DMEPOS
suppliers participating in competitive
bidding to ensure that any subcontractor
obtains and maintains all appropriate
State licenses in the area where they are
providing services. We maintain that
DMEPOS suppliers awarded a
competitive bidding contract and that
are subcontracting will be allowed on a
phase-in basis for licenses services and
licensed professionals participating in
competitive bidding.
Comment: One commenter believes
that this regulation is in conflict with
some State licensing requirements, as
some States permit DMEPOS suppliers
to comply with its State licensing
requirements by contracting with an
individual or other entity to provide the
licensed service. In addition, the
commenter states a Federal regulation
cannot supersede the historic police
powers of the State unless it was the
clear and manifest purpose of the
Congress (see Downhaur v. Somani).
Response: We agree with this
commenter because, State licensing
laws and regulations on the licensure of
DMEPOS suppliers govern how
DMEPOS suppliers furnish items within
a particular State. Therefore, we
maintain that a DMEPOS supplier can
contract for licensed services only when
the State where the licensed service is
being provided allows for this sort of
arrangement consistent with
§ 424.57(c)(1)(ii)(C).
Comment: A commenter does not
believe that CMS should be in the
business of professional licensing.
Response: It is important to note that
we require the DMEPOS supplier to be
State licensed, not to obtain a license
from CMS. This change will help to
ensure that DMEPOS suppliers are
meeting State licensing requirements.
Comment: Several commenters
recommended that the provision of not
contracting out licensed services and
the W–2 employee provisions of this
standard only apply when not
addressed by State licensing
requirements.
Response: We agree with these
commenters. We believe that DMEPOS
suppliers must meet all applicable State
licensing requirements and that this
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
52634
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
standard will only apply when not
addressed by State licensing
requirements.
Comment: Several commenters do not
believe it should matter if the service is
furnished by a W–2 employee or a 1099
contractor so long as both are properly
licensed with no adverse legal action
current or pending.
Response: We agree with these
commenters because a DMEPOS
supplier is accountable for meeting the
applicable State licensing requirements,
and by requiring that W–2 employees or
a 1099 contractor (when allowed by
State law) of the supplier are
appropriately licensed, the NSC can
verify that a DMEPOS supplier is
meeting all applicable State licensing
requirements.
Comment: One commenter stated that
they are opposed to the revisions in
§ 424.57(c)(1) because it would prevent
all but the largest DMEPOS suppliers
from bidding on contracts under the
DMEPOS competitive bidding program
because smaller businesses would not
be able to hire staff all the potential
licensed professionals as W–2
employees.
Response: We want to clarify that the
employment requirement will not apply
to contract suppliers participating in the
competitive bidding program and we
have reflected this intention in
§ 424.57(c)(1)(ii)(B).
Comment: Several commenters
believe that the proposed rule conflicts
with the rules for participation in the
competitive bidding program, as the
competitive bidding program itself
allows items and services in a product
category to be supplied directly or
through a subcontractor and provides
safeguards to allow subcontracting.
Response: We agree with these
commenters, and have revised
§ 424.57(c)(1)(ii)(B) to reflect that the
employment requirement for the
furnishing of licensed services does not
apply to contract suppliers participating
in the competitive bidding program.
Comment: One commenter stated that
this regulation conflicts with CMS’
accreditation standards which permit
contracting for licensed services, so long
as the DMEPOS supplier complies with
State licensure laws and is ultimately
responsible for the services provided by
a contractor.
Response: We have amended
§ 424.57(c)(1) to permit contracting for
licensed services, so long as the State
where the licensed services are being
performed allow for such contracting
and the DMEPOS supplier complies
with State licensure laws and is
ultimately responsible for the services
provided by a contractor. The supplier
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
standards in § 424.57 are separate from
the quality standards which are used by
accrediting organizations. This
regulation does not conflict with our
accreditation standards listed at
§ 424.57(c)(22) through (c)(25).
Comment: A commenter stated that
the proposed rule is unnecessary
because many of the DMEPOS suppliers
must be accredited by September 30,
2009 on top of already having to meet
the State licensure requirements.
Moreover, supplier’s ability to use
subcontractors for the purpose of
assuring service throughout a
competitive bidding area would be
limited which could disadvantage the
small suppliers compared to large
suppliers.
Response: We disagree with these
commenters because a DMEPOS
supplier is accountable for meeting the
applicable State licensing requirements,
and by requiring DMEPOS suppliers to
employ individuals who are
appropriated licensed, the NSC can
verify that a DMEPOS supplier is
meeting all applicable State licensing
requirements.
Comment: Several commenters stated
that the standard to prohibit a DMEPOS
supplier from contracting with an
individual or other entity to provide the
licensed service places an unfair burden
on small suppliers who at times must
contract with licensed personnel or
provide specific services to the
supplier’s patients. Also, this
requirement makes it seem like CMS is
singling out DMEPOS suppliers by not
allowing them the use of staffing
agencies when demand is great. In
addition, the commenter believes that
this standard would restrict suppliers
that have full time respiratory therapists
from hiring temporary licensed
respiratory therapists during times of
vacation, illness or increased staffing
needs, and have a detrimental effect on
patient’s access to care and restrict
respiratory therapists from performing
duties in the patient’s home.
Response: We believe that a DMEPOS
supplier must be licensed to provide
licensed services, and therefore, we are
not adopting any exceptions to this
provision except where a State permits
contracting for licensed services. In
addition, many small businesses
currently have an owner or W–2
employee who is licensed to provide a
service that requires a State licensure.
We believe that the changes we are
adopting in this final regulation will not
have a detrimental effect on patient’s
access to care and do not restrict
respiratory therapists from performing
duties in the patient’s home. Finally, as
stated previously, we are clarifying that
PO 00000
Frm 00028
Fmt 4700
Sfmt 4700
DMEPOS supplier may hire a licensed
W–2 employee on a part-time or fulltime basis and we will permit
contracting for licensed services, so long
as the State permits contracting for
licensed services and the DMEPOS
supplier complies with State licensure
laws and is ultimately responsible for
the services provided by a contractor.
Comment: One commenter asks how
disallowing the contracting of licensed
individuals could affect competitive
bidding, given that a supplier is
required to submit a bid for all of the
oxygen modalities.
Response: When allowed under State
law, we will permit contracting for
licensed services, so long as the
DMEPOS supplier complies with State
licensure laws and is ultimately
responsible for the services provided by
a contractor. In order for a DMEPOS
supplier to be able to participate in the
DMEPOS competitive bidding program,
the supplier must comply with all of the
DMEPOS supplier standards and be
enrolled in the Medicare program as a
DMEPOS supplier.
Comment: One commenter asked if
this rule is requiring all oxygen
suppliers to directly provide liquid
oxygen since CMS competitive bidding
rules allow for contracting in certain
areas.
Response: No, all oxygen suppliers do
not need to directly provide liquid
oxygen. A supplier can use a qualified
subcontractor to deliver oxygen. If the
supplier is not in a competitive bidding
area and does not furnish liquid oxygen
as part of their business model and the
prescription specifically indicates that
the physician is ordering liquid oxygen,
the supplier would either need to get
approval from the ordering physician to
furnish a different modality or refer the
beneficiary to another supplier. If a
physician orders liquid oxygen in areas
that fall under competitive bidding,
then the oxygen supplier must supply
liquid oxygen.
Comment: A commenter stated that
the proposed rule would result in
different Federal requirements for
hospital-based DMEPOS suppliers based
solely on the location of the supplier
and further disadvantage hospitals
because hospitals generally use
independent contractors to perform its
services.
Response: We disagree with this
commenter because all DMEPOS
suppliers, including those based at
hospitals or operated by other providers,
are required to meet State licensing
requirement for the services they
provide. This change will enable CMS
or our designated contractor to verify
that the supplier is meeting the
E:\FR\FM\27AUR1.SGM
27AUR1
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
WReier-Aviles on DSKGBLS3C1PROD with RULES
applicable State licensing requirements
for the services that it furnishes.
2. Physical Facility—Appropriate Site
In § 424.57(c)(7), we proposed to
clarify the supplier standard for
maintaining a physical facility on an
appropriate site. Specially, we proposed
to clarify the term, ‘‘appropriate site.’’ In
addition, we stated that an ‘‘appropriate
site’’ applies to ‘‘closed door’’ businesses
(such as pharmacies/suppliers
providing services only to beneficiaries
residing in a nursing home). We also
solicited comments on whether we
should establish a minimum square
footage requirement to the definition of
an appropriate site and what, if any,
appropriate exceptions would apply to
a minimum square footage requirement.
Comment: One commenter
recommended that a minimum square
footage requirement be established so
the suppliers cannot qualify for
participation in the Medicare program
with unsuitable locations. This
commenter stated that square footage
should be adequate to store the
necessary inventory.
Response: We appreciate this
comment and have adopted a minimum
square footage requirement of 200
square feet in § 424.57(c)(7). We agree
with this commenter that a DMEPOS
supplier must maintain a minimum area
of space for inventory, storage, and
including patient records.
Comment: Several commenters stated
that the variability between suppliers
and services provided are too great to
set a minimum number of square feet
required to attain a supplier number.
Response: We appreciate these
comments and considered them in
establishing minimum square footage
requirements within § 424.57(c)(7).
Comment: A number of commenters
opposed the establishment of a specific
square footage requirement for supplier’
physical locations.
Response: Since many DMEPOS
suppliers who do not have a minimum
square footage have been determined in
the past to be fraudulent suppliers or
have provided less than sufficient
services to Medicare beneficiaries, we
believe that a minimum square footage
requirement is necessary to ensure that
DMEPOS suppliers are operating a
legitimate business. However, based on
public comments, we were concerned
that establishing a minimum square
footage requirement of 500 square feet
may impose an undue burden for some
suppliers. Accordingly, based on public
comments and our review of existing
supplier operations, we are adopting a
minimum square footage of 200 square
feet per practice location. We believe
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
that 200 square feet represents the
smallest practice location that can be
used to meet the supplier standards in
§ 424.57. Specifically, we would expect
that most practice locations have space
for inventory, storage, including patient
records, a desk and chairs, and in most
cases a restroom for employees and
customers.
Comment: One commenter
recommended that we clarify that
DMEPOS suppliers may continue to
utilize centralized business centers to
house beneficiary and other business
records and centralized customer call
centers are permissible under this
revised standard.
Response: We believe that it is
necessary to have prompt access to
delivery, maintenance, and beneficiary
records at the supplier’s facility where
the beneficiary receives services. This
enables the beneficiary to promptly
obtain necessary information and for
CMS and our agents to perform a review
of the records. We agree that the use of
a centralized business center by a
multisite supplier to house these
records when the information in the
records can be furnished to the
beneficiary or CMS and our agents, or
both. For example, the supplier location
could use a computer terminal to access
the records which are being stored off
site. Then, it could express mail the
documents requested.
Comment: A commenter stated that it
is not economically feasible for a small
supplier to maintain a storefront.
Response: We do not require that a
DMEPOS supplier maintain a storefront,
and if the DMEPOS supplier chooses to
maintain a storefront, it may be coupled
with its storage space for DMEPOS.
However, if the supplier is in a
commercial building, the sign can be
posted at the entrance of the building.
We believe that it is essential for our
beneficiaries and site reviewers to be
able to promptly locate the supplier.
Therefore, the signage must be readily
visible to the general public. We
understand the concerns that additional
costs may be incurred for small
businesses. However we believe that the
majority of our DMEPOS suppliers
already meet this requirement.
Additionally, those DMEPOS suppliers
with less than the 200 square foot
minimum space and who have entered
into a long term lease before the
publication of this final rule will have
time to transition into a new location, as
explained later in this rule.
Comment: Several commenters stated
that they do not support CMS’ proposal
to micromanage a supplier’s business
operation by dictating size, hours,
staffing, and access via a single standard
PO 00000
Frm 00029
Fmt 4700
Sfmt 4700
52635
without exception for the specific
services being furnished.
Response: We believe that the
provisions of § 424.57(c)(7) are designed
to ensure that DMEPOS suppliers
conform to generally accepted business
practices employed by quality suppliers.
Comment: Several commenters
believe it would be in CMS’s best
interest to retain the current policy
which allows for a central record storage
location for multi-State DME suppliers.
Response: We agree that multistate
DME suppliers can maintain central
record storage locations and have
amended the regulations text in
§ 424.57(c)(7)(i) to reflect this concern.
Comment: One commenter stated that
there can be a problem with the
requirement of external signage when it
conflicts with local zoning ordinances.
Response: We believe that prospective
suppliers of DMEPOS and existing
suppliers of DMEPOS must understand
and comply with the supplier standards
found in this section. Accordingly,
prospective suppliers of DMEPOS
should ensure that their practice
location meets the requirements found
in § 424.57(c)(7) and the other supplier
standards found in this section prior to
buying or entering into a leasing
arrangement for a given practice
location. For example, if the owner of
prospective supplier of DMEPOS knows
or should have known that local zoning
ordinances preclude the establishment
of home-business in a residential
neighborhood, then the prospective
supplier of DMEPOS should make the
business decision to: (1) Obtain a waiver
to the local zoning ordinance in advance
of submitting their enrollment
application to the NSC; or (2) select a
different practice location that will
ensure the supplier’s compliance with
the requirements specified in
§ 424.57(c)(7).
Comment: One commenter stated that
it may not be possible to fulfill the
signage requirement because the owner
of the building may not allow the
posting of the sign, and that the patients
that they see are by appointment only so
posting a sign with office hours is not
necessary.
Response: As previously stated, we
believe that prospective suppliers of
DMEPOS and existing suppliers of
DMEPOS must understand and comply
with the supplier standards found in
this section. Accordingly, prospective
suppliers of DMEPOS should ensure
that their practice location meets the
requirements found in § 424.57(c)(7)
and the other supplier standards found
in this section prior to buying or
entering into a leasing arrangement for
a given practice location. Accordingly,
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
52636
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
we disagree with this commenter, and
believe that it is essential that the
beneficiaries and CMS agents can
clearly see where the supplier is located
and the supplier’s hours of operation. If
the building owner will not allow the
posting of hours of operation, then the
DMEPOS supplier should consider the
supplier site to be inappropriate for a
business that serves Medicare
beneficiaries. Even for suppliers that
take appointments, we believe that
proper signage and posted hours are
required for proper beneficiary
information.
Comment: One commenter believes it
is not always possible to give the NSC
prior notice to a change in the hours of
operation.
Response: While we understand that
suppliers have 30 days to notify the
NSC of change in posted business hours,
we do not believe that legitimate
suppliers routinely change their posted
hours of operation frequently. Moreover,
there is nothing in our current rules or
within this final regulation which
precludes a DMEPOS supplier from
notifying the NSC prior to or at the time
a change of posted business hours are
implemented.
Comment: A commenter stated that
size and space requirements are already
established in the accreditation process,
and therefore, are unnecessary as a
separate supplier standard.
Response: Since the requirements
included within accreditation standards
set forth in § 424.57(c)(21) through
§ 424.57(c)(25) and quality standards are
independent of the supplier standards
in § 424.57, we believe that it is
appropriate to establish a minimum
square footage requirement to assist us
in determining whether a DMEPOS
supplier is operating a legitimate
business as neither of the
aforementioned sets of standards
include a provision for minimum square
footage.
Comment: One commenter requested
what defines a permanent, durable sign
and noted that sometimes it may be
necessary to have permanent signage
attached to the glass panel of a facility.
Response: While we have not defined
what constitutes a permanent durable
sign, there is no requirement that a
permanent sign be or not be attached to
a glass panel.
Comment: Several commenters
suggested that an exemption should be
granted when it is necessary for the
office to be temporarily closed during
posted office hours to account for
holidays, natural disasters, short-term
closures, patient deliveries,
emergencies, and other unforeseen
occurrences.
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
Response: We note that we have
always made exceptions concerning
posted hours for disasters and
emergencies and Federal and State
holidays. However, while we recognize
that personal emergencies do occur, we
believe that suppliers should be
available during posted business hours.
Moreover, we believe that a DMEPOS
supplier should do its best to plan and
staff for temporary absences.
Comment: One commenter believes
the minimum square footage
requirement causes potential issues for
orthotic and prosthetic suppliers since
the lab area is separate from the patient
area and is often located off-site. The
patient interaction area is most
important, but since this area can be as
small as 80 square feet, the size
requirement should not be imposed as
to orthotic and prosthetic suppliers.
Response: We agree with the concerns
raised by this commenter and have
adopted an exception to § 424.57(c)(7)
for State-licensed orthotic and
prosthetic personnel in private practice
as one of the exceptions to this
provision.
Comment: One commenter suggests
that rather than mandating a certain
amount of square footage, an alternative
could be a rule indicating that the office
space must consist of an ADA accessible
reception area, a minimum of one
examination room and a restroom,
unless there is a common area restroom.
Response: We believe that it would be
very difficult for us to develop
specifications for these items. Moreover,
we believe that doing so would likely be
more restrictive for some types of
suppliers.
Comment: One commenter notes that
in most leased spaces, especially in
medical buildings, the signage locations
are predetermined, and therefore, the
commenters do not believe a quality
standard should mandate signage on the
exterior of the building.
Response: We believe that the sign
must be visible at the main entrance of
the facility and visible to the public.
Therefore, in a public medical building,
the sign could be posted in the main
lobby entrance if access to the lobby is
available to the general public.
Comment: One commenter
recommended that if CMS does set
minimum square footage requirements
that we give suppliers time for the
expiration of current leases and to
obtain a new location or ‘‘grandfather’’
locations already in use.
Response: We agree with this
commenter and will establish a 3-year
phase-in period for those existing
suppliers of DMEPOS who have signed
leases, including long-term leases, on or
PO 00000
Frm 00030
Fmt 4700
Sfmt 4700
before the publication date of this final
rule. We believe that this phase-in
period will provide small businesses
with sufficient time to identify a
practice location that meets the
minimum square footage requirement.
We will make this requirement effective
for existing DMEPOS suppliers 3 years
from the effective date of this regulation.
However, we do not believe that it is
appropriate to establish a similar
requirement for prospective suppliers of
DMEPOS, including those suppliers
who have a pending enrollment
application with the NSC.
Consequently, we expect prospective
DMEPOS suppliers to comply with this
requirement as of the effective date of
this regulation. As prospective DMEPOS
suppliers seek billing privileges after the
effective date of this regulation, we
expect them to comply with this
requirement in order to be enrolled in
Medicare.
Comment: One commenter is
concerned that the minimum square
footage requirement may be over
interpreted as a means to shut down
legitimate suppliers (for example, a
legitimate supplier being 25 feet short
after the rule becomes effective but
having a 5-year lease to fulfill).
Response: We proposed the minimum
square footage as a basis for ensuring
that legitimate suppliers are meeting the
supplier standards in § 424.57 and that
these suppliers are providing quality
products and services to Medicare
beneficiaries. As stated previously, we
will impose this requirement on those
suppliers who have entered into leases,
including long-term leases, on or before
the date of publication of this final rule.
Accordingly, we maintain that DMEPOS
suppliers who had entered into lease
arrangements of 1 year or less must
come into compliance with this
provision at the end of their current
lease. Similarly, DMEPOS suppliers
who have entered into leasing
arrangements of more than 1 year but
less than 3 years must come into
compliance with this standard at the
end of their current lease; and that all
existing DMEPOS suppliers must come
into compliance with this standard
within 3 years of the effective date of
this final rule.
Finally, while we are establishing a
transition period for implementation of
this requirement for DMEPOS suppliers
already enrolled in the Medicare
program, we are not adopting a
transition period for DMEPOS suppliers
enrolling a new practice location,
reactivating the billing privileges for a
DMEPOS supplier previously enrolled
in the Medicare program or for DMEPOS
suppliers changing their existing
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
practice location or selling their existing
practice location.
Comment: One commenter notes that
licensing and accrediting bodies inspect
suppliers’ facilities to assure the
supplier has a legally defined means of
providing care. The commenter believes
that Medicare should have no role in
determining the appropriateness of a
supplier’s facility.
Response: While we agree that
licensing and accreditation are essential
elements for ensuring quality of care, we
disagree with the commenter that CMS
or our designated contractor should
have no role in determining the
appropriateness of a supplier’s facility.
Since the implementation of the
DMEPOS supplier standards in October
of 2000, we have played an important
role in determining the appropriateness
of a supplier’s facility via regulation at
§ 424.57.
Comment: One commenter questioned
why the square footage matters if a
supplier meets all requirements and has
Medicare beneficiaries coming to the
supplier’s physical location where
products are stocked and provided.
Response: We maintain that an
appropriate amount of square footage is
generally necessary to ensure that the
facility can meet its obligations to a
beneficiary which include an area for
the beneficiary to sit, or room for a
wheelchair and room for it to turn/move
around, as well as room for stock and
for the equipment necessary for running
a business. In addition, in the past many
suppliers with very minimal square
footage have been determined to be
fraudulent or have provided inferior
service to Medicare beneficiaries.
Comment: One commenter questioned
whether it is CMS’ intent to require
suppliers to be a retail-type business by
mandating minimum square footage
which needlessly drives up the cost of
doing business for nonretail suppliers.
Response: While ‘‘closed door’’
businesses are eligible to participate in
the Medicare program, we believe that
it is necessary to include a minimum
square footage into what is considered
an appropriate site. We understand
there may be concern that this
requirement may cause a change in
business practices for smaller suppliers
and could possibly result in increased
costs. However, we believe that most
DMEPOS suppliers are already meeting
this standard.
Comment: A commenter stated that
the minimum square footage
requirement is not appropriate because
the Federal rule would preempt State or
local land use or supplier laws already
in place and will not take into account
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
the supplier’s operations or the needs of
the beneficiaries being serviced.
Response: We disagree with this
commenter. While we are not
preempting State and local land use
laws, we are establishing criteria to
enroll in the Medicare program as a
DMEPOS supplier. We believe that this
revised criterion will help to ensure that
Medicare beneficiaries receive quality
services from quality suppliers.
Comment: A commenter stated that
the minimum square footage
requirement is unnecessary for
suppliers’ facilities that are not intended
for beneficiary access and that this
proposed standard blurs the distinction
between a classic retail establishment
and a service facility dedicated to the
provision of supplies and equipment to
patients in their homes. In addition, the
commenter requests that CMS consider
different business models for supplier
standards, including suppliers that
provide quality items and services to
beneficiaries, but do not operate
facilities intended to be stores for inperson access.
Response: We disagree with this
commenter. Since most DMEPOS
suppliers are not solely service
facilities, we believe that these enrolled
suppliers must provide reasonable
access for Medicare beneficiaries in the
event that a beneficiary has a problem
or requires prompt service. It is also
essential that CMS or our agents have
access during posted hours of
operations to ensure that the supplier
continues to meet the supplier
standards in § 424.57.
Comment: A commenter suggests that
CMS consider that the appropriate size
of a facility is based on the services
provided, the size of the organization
and the status of the location.
Response: We appreciate this
comment and have considered these
factors in adopting a minimum square
footage requirement for DMEPOS
suppliers. As noted previously, we
maintain that an appropriate amount of
square footage is generally necessary to
ensure that the facility can meet its
obligations to a beneficiary which
include an area for the beneficiary to sit,
or room for a wheelchair and room for
it to turn/move around, as well as space
for inventory, patient records and
equipment necessary for running a
business.
3. On-Site Inspections
In § 424.57(c)(8), we proposed to
clarify this provision by revising (c)(8)
to read as follows: ‘‘Permits CMS, the
NSC, or agents of CMS or the NSC to
conduct on-site inspections to ascertain
PO 00000
Frm 00031
Fmt 4700
Sfmt 4700
52637
supplier compliance with the
requirements of this section.’’
Comment: One commenter
recommended that instead of revoking a
supplier’s billing privileges when a site
visit cannot be conducted, the NSC
should ‘‘suspend’’ the billing privileges
pending further investigation to
determine if the entity is a legitimate
supplier.
Response: We do not have statutory or
regulatory authority to suspend billing
privileges under those circumstances.
However, we note that DMEPOS
suppliers are afforded appeal rights if
their billing privileges are revoked.
Comment: A commenter believes
routine on-site visits should be by
appointment to ensure proper person(s)
are available.
Response: We disagree with this
commenter. While we understand that
proper staff may not always be on-site
when unannounced site visits occur, it
is necessary for all DMEPOS suppliers
to be open during posted hours of
operations. The revised language only
clarifies who is authorized to conduct
the on-site visit. Moreover, we believe
that unannounced site visits are
necessary to ensure that a DMEPOS
supplier is continually meeting the
supplier standards in § 424.57.
Comment: Several commenters
believed that it would be unjust to deny
or revoke based on one site visit during
posted hours because the business could
be closed for a legitimate reason on the
day of the visit, the mandated staff may
be on call, or that another emergency
situation may occur that would prevent
a DMEPOS supplier from being open
during posted hours of operation.
Response: While we understand that
unexpected or emergency business
closings can occur, we believe that it is
essential that DMEPOS suppliers
establish practices and procedures to
address unexpected or emergency
situations. In addition, we understand
the nature of unforeseen emergencies
and when warranted, the NSC will
conduct an unannounced follow-up
visit prior to denying or revoking billing
privileges.
Comment: One commenter believes
this requirement constitutes over
regulating by the government.
Response: We disagree with the
commenter. We have found
unannounced on-site visits to be a very
effective tool in combating fraud and
abuse and to protect the Medicare Trust
Fund from unscrupulous suppliers.
Moreover, CMS and our designated
contractor, the NSC, have conducted
unannounced on-site visits since 2000
to ensure compliance with those
E:\FR\FM\27AUR1.SGM
27AUR1
52638
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
standards which only can be verified by
visual inspection.
WReier-Aviles on DSKGBLS3C1PROD with RULES
4. Business Telephone Operations
In § 424.57(c)(9), we proposed a
revision of this standard so that it would
read, ‘‘Maintains a primary business
telephone that is operating at the
appropriate site listed under the name
of the business locally or toll-free for
beneficiaries. The use of cellular
phones, beeper numbers, and pagers is
prohibited. Additionally, DMEPOS
suppliers are prohibited from
forwarding calls from the primary
business telephone listed under the
name of the business to a cellular
phone, or a beeper/pager. The exclusive
use of answering machines, answering
services or facsimile machine (or
combination of these options) cannot be
used as the primary business telephone
during posted operating hours.’’
Comment: One commenter requested
that we clarify that all call forwarding
to a main business office number when
multiple office locations exist would be
permitted.
Response: While we appreciate this
comment, we do not believe that it is
appropriate for a DMEPOS supplier to
forward calls from one practice location
to a main business office number when
multiple practice locations exists.
Comment: One commenter stated that
preventing the use of alternative
technologies during business hours
would have an adverse effect on the
quality of services that suppliers are
able to furnish to Medicare
beneficiaries.
Response: While we appreciate this
comment, we believe that the supplier
standards in § 424.57(c)(9) are not
overly prescriptive and help to ensure
that the DMEPOS supplier is
operational during posted hours of
operations.
5. Comprehensive Liability Insurance
In § 424.57(c)(10), we proposed a
revision to this provision to specify that
the DMEPOS supplier has a
comprehensive liability insurance
policy in the amount of at least
$300,000 per incident that covers both
the supplier’s place of business and all
customers and employees of the
supplier and ensures that insurance
policy must remain in force at all times.
In addition, we proposed that a
DMEPOS supplier must list the NSC as
a certificate holder on the policy and
notify the NSC in writing within 30
days of any policy changes or
cancellations. Although we are not
finalizing the proposed revision in this
final rule, we will consider this
provision in a future rulemaking.
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
6. Solicitation of Beneficiaries
In § 424.57(c)(11), we proposed to
revise this supplier standard to clarify
that suppliers and their agents cannot
make a direct solicitation of Medicare
beneficiaries, which includes, but is not
limited to, telephone, computer, e-mail,
instant messaging, or in-person contacts,
except under the current provisions at
§ 424.57(c)(11)(i) through (iii).
Comment: One commenter
recommended that we retract the
proposed provision and allow the
current telephone standard to remain
unchanged. This commenter also stated
that a supplier is not ‘‘cold calling’’ the
beneficiary when the supplier has
received a verbal order from a physician
and requested that we clarify that a
supplier is not violating this standard if
the supplier contacts a beneficiary via
telephone after it has received a verbal
order from the beneficiary’s treating
physician.
Response: We do not agree. We
believe that it is inappropriate for a
DMEPOS supplier to contact a
beneficiary based solely on a physician
order. In the situation described by the
commenter, the contact is without the
beneficiary’s knowledge that the
physician would be contacting a
supplier on the beneficiaries behalf and
would be prohibited unless one of the
current provisions in § 424.57(c)(11)(i)
through (iii) applied. However, if a
physician contacts the supplier on
behalf of the beneficiary’s with the
beneficiary’s knowledge, and then a
supplier contacts the beneficiary to
confirm or gather information needed to
provide that particular covered item
(including the delivery and billing
information), then that contact would
not be considered a direct solicitation
for the purpose of this standard. This is
the case even if the physician has not
specified the precise DMEPOS supplier
that will be contacting the beneficiary
regarding the item referred by that
physician.
Comment: One commenter stated that
CMS lacks the statutory authority to
expand on the longstanding statutory
and regulatory prohibition on
unsolicited telephone contacts to further
types of speech.
Response: We disagree with the
commenter’s assertion that we are trying
to expand on the statutory authority
which prohibits unsolicited telephone
contacts set forth in section 1834(a)(17)
of the Act. We believe that we have the
statutory authority to clarify and revise
the supplier standard in § 424.57(c)(11).
Specifically, section 1834(j)(1)(B) of the
Act gives the Secretary the authority to
establish additional supplier standards.
PO 00000
Frm 00032
Fmt 4700
Sfmt 4700
In addition, section 1871 of the Act
provides the Secretary the right to
prescribe regulations as may be
necessary to carry out the
administration of the Medicare program.
Moreover, we believe that it is necessary
to review, clarify, and, if necessary,
revise existing regulatory standards to
address changes in practice by DMEPOS
suppliers in order to protect Medicare
beneficiaries and the Medicare Trust
Funds.
Comment: Several commenters stated
that our proposal to clarify and revise
§ 424.57(c)(11) violated First
Amendment protections by
unconstitutionally restricting
commercial speech. In addition, this
commenter stated that, ‘‘Business
solicitation by DME suppliers is clearly
a form of commercial speech as any
business has the right to market its
products to potential customers.
Advertising by suppliers of medical
equipment is not inherently misleading
and can be an important method of
informing beneficiaries of products and
services that are covered or accessible
under their Medicare coverage.’’
Response: We disagree that the
revisions that we are adopting in
§ 424.57(c)(11) of this final rule deny or
abridge First Amendment rights.
Specifically, this revised standard does
not change or alter a DMEPOS
supplier’s ability to advertise its
products and services to the general
public or Medicare beneficiaries
generally. As such, television, radio,
and Internet advertisements are
permitted. In addition, DMEPOS
suppliers may advertise their products
or services at health fairs, community
events, or the DMEPOS supplier’s Web
site. This provision seeks to prohibit a
supplier from making direct
solicitations with Medicare beneficiaries
without their consent.
Comment: One commenter stated that
the proposed change to § 424.57(c)(11)
would harm Medicare beneficiaries and
all healthcare consumers. This
commenter also stated that this proposal
would have the effect of limiting
consumer education, price comparison,
and overall choice.
Response: We disagree with this
commenter that the changes we are
adopting in this final rule will limit
consumer education, price comparison
or overall choice because suppliers can
continue to educate the public about the
advantages of their products or services
through marketing practices that help to
educate and inform the public and
Medicare beneficiaries about their
healthcare choices.
Comment: One commenter stated that
if a beneficiary visited a retail store, on
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
their on volition, to seek information on
DMEPOS products, that the proposed
change would prohibit the supplier
from providing information or
education that the beneficiary
requested.
Response: We disagree that a
DMEPOS supplier could not provide
information or education when the
beneficiary contacts the DMEPOS
supplier for information. The revised
supplier standard in § 424.57(c)(11)
states that DMEPOS suppliers must
agree not to directly solicit patients,
except as permitted under the current
provisions in § 424.57(c)(11)(i) through
(iii). Accordingly, if the Medicare
beneficiary initially contacts the
DMEPOS supplier, then the supplier’s
contact with the beneficiary would not
be a direct solicitation and the supplier
may, therefore, discuss, educate, and
inform the Medicare beneficiary about
the various products and alternatives
available to that beneficiary.
Comment: One commenter stated that
we did not adequately define, ‘‘directly
solicit’’ or ‘‘coercive internet
advertising.’’
Response: We appreciate the request
for clarification. We believe that ‘‘direct
solicitation’’ occurs when a DMEPOS
supplier or its agents directly contacts
an individual Medicare beneficiary by
telephone, e-mail, instant messaging, or
in-person contact without his or her
consent for the purpose of marketing the
DMEPOS supplier’s health care
products or services or both. In
addition, we removed the reference to
‘‘coercive response internet advertising’’
from this rule in order to ensure that
this standard is clear and
understandable.
Comment: One commenter asked if
internet advertising such as internet
‘‘yellow pages,’’ the use of Google
AdWords, appearance in search engine
results or other ‘‘keyword’’
advertisements informing the public of
products and services provided by a
supplier would constitute coercive
response Internet advertising.
Response: As noted previously, we
removed the reference to ‘‘coercive
response Internet advertising’’ from this
final rule in order to ensure that this
standard is clear and understandable.
We believe that advertising techniques
such as internet yellow pages, Google
AdWords, and search engine keyword
result-driven advertising are techniques
used by businesses to educate and
inform the public about a company and
its products. In addition, these practices
are normally considered mass
advertising. Accordingly, web site
advertisements that are intended to
market a DMEPOS supplier to the
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
general public are permissible and are
not considered direct solicitation for the
purpose of this standard.
Comment: Several commenters would
like CMS to clarify the restrictions on a
supplier who may contact a Medicare
recipient about noncovered items
because it appears to limit a supplier’s
legitimate marketing activities such as
web pages describing various products,
services and inserts to periodical
publications dealing with various
products and services.
Response: We do not agree that this
standard limits a supplier’s legitimate
marketing activities. We believe that
DMEPOS suppliers can continue to
conduct mass advertising. For the
purposes of this final rule, we believe
direct solicitation targets Medicare
beneficiaries without their consent.
Accordingly, we believe that direct
solicitation is significantly different in
scope than general advertising. Again,
these solicitations are one on one in
nature and not the same as general
advertising to the public and also apply
to noncovered items if they are being
solicited by a Medicare enrolled
DMEPOS supplier.
Comment: One commenter asks if a
web site dedicated to short-term cash
rentals of not readily-accessible portable
oxygen concentrators for travel use
(using an Advance Beneficiary Notices
(ABN) if the customer is a Medicare
beneficiary) violates the provisions
outlined in the proposed rule.
Response: We believe, for the purpose
of this standard, a web site dedicated to
short-term cash rentals of not-readily
accessible portable oxygen
concentrators for travel use to be of use
to the general public. Using ABNs if the
customer is a Medicare beneficiary
would be required for the supplier to
not be held liable for the charge under
section 1879 of the Act. Using ABNs
assists the beneficiaries in making
informed decisions about the product. A
dedicated web site that can be freely
accessed by the general public, at the
consumer’s choice, is not considered
direct solicitation for the purpose of this
standard.
Comment: Several commenters
suggested that the standard is
satisfactory as it exists and that
changing it as proposed would be overly
restrictive, burdensome, and could
prevent patients from receiving
important information.
Response: We believe the revision of
this standard was necessary to include
current trends and technological
advances, such as door-to-door
solicitation, electronic mail, and instant
messaging. However, we do not believe
this provision would prohibit DMEPOS
PO 00000
Frm 00033
Fmt 4700
Sfmt 4700
52639
suppliers from contacting Medicare
beneficiaries in the situations described
in the current provisions in
§ 424.57(c)(11)(i) through (iii). For
example, a supplier could contact a
beneficiary with whom they already
have an established business
relationship or for legitimate reasons,
such as annual fitting reminders,
updating or verifying information from
previously serviced beneficiaries.
Comment: Several commenters
recommended that we add another
reason for the DMEPOS supplier to
contact the patient, namely when the
physician places the DMEPOS order
(written or verbal) on behalf of the
patient.
Response: As noted previously, a
DMEPOS supplier may not contact a
beneficiary based solely on a physician
order. However, a supplier may contact
a beneficiary if a physician contacts a
DMEPOS supplier on behalf of a
beneficiary with the beneficiary’s
knowledge, and then a supplier contacts
the beneficiary to confirm or gather
information needed to provide that
particular covered item (including
delivery and billing information). In that
instance, the contact would not be
considered a direct solicitation and
therefore, would not implicate the
standard set forth at § 424.57(c)(11).
Please note that the beneficiary need
only be aware that a DMEPOS supplier
will be contacting him/her regarding the
prescribed covered item, recognizing
that the appropriate supplier may not
have been identified at the time of the
consultation.
Comment: A commenter stated that
prohibiting a supplier from directly
soliciting patients, including ‘‘in-person
contacts’’ improperly restrains free
speech and disadvantages a small
supplier by limiting a supplier to mass
media advertising, which is only
financially feasible to large suppliers.
The commenter also stated that the
beneficiary will be adversely affected
because, under the proposed rule, a
member of the hospital staff would need
to obtain written permission from the
beneficiary and transmit that permission
to the supplier before the supplier could
initiate the service causing unnecessary
waiting periods.
Response: We believe that a ‘‘direct
solicitation’’ occurs when a DMEPOS
supplier or their agent contacts an
individual Medicare beneficiary without
their consent for the purpose of
marketing the DMEPOS supplier’s
health care products or services or both;
therefore we are clarifying our
regulations by adding the definition of
‘‘direct solicitation’’ to § 424.57(a). These
types of direct solicitations are one on
E:\FR\FM\27AUR1.SGM
27AUR1
52640
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
one in nature and not the same as
advertising to the public in a general
marketing campaign. Finally, we do not
believe Medicare beneficiaries will be
adversely affected by this provision’s
contact restrictions causing unnecessary
waiting periods prior to a DMEPOS
supplier’s initiation of services. As long
as the beneficiary has completed a
consent form giving the hospital staff
member permission to share the
beneficiary’s information with the
DMEPOS supplier for the purpose of
initiating service, the hospital staff
person can order the service on the
beneficiary’s behalf. Hospitals or other
entities use consent forms for the
purpose of ordering medical supplies or
services on behalf of patients as
standard operating procedure to ensure
compliance with the Privacy Act and its
implementing regulations.
7. Product Delivery and Beneficiary
Instructions
In § 424.57, we proposed to revise
paragraph (c)(12) provision to clarify its
intent. Specifically, we proposed that a
DMEPOS supplier: (1) Is responsible for
maintaining proof of the delivery in the
beneficiary’s file; (2) must furnish
information to beneficiaries at the time
of delivery of items as to how the
beneficiary can contact the supplier by
telephone; (3) must provide the
beneficiary with instructions on how to
safely and effectively use the equipment
or contract this service to a qualified
individual; (4) is responsible for
providing instruction on the safe and
effective use of the equipment that
should be completed at the time of
delivery; and (5) must document that
this instruction has taken place. We are
continuing to review the public
comments received on this provision
and we will consider finalizing this
provision in a future rulemaking effort.
B. New DMEPOS Supplier Standards
WReier-Aviles on DSKGBLS3C1PROD with RULES
1. Obtaining Oxygen
In § 424.57(c)(27), we proposed a new
standard that specified that the
DMEPOS supplier must obtain oxygen
from a State-licensed oxygen supplier.
In addition, we stated that the proposed
new standard would not apply when the
State does not license oxygen suppliers.
Comment: One commenter stated that
they generally agree that DMEPOS
suppliers should obtain oxygen from
appropriately licensed oxygen supply
companies, but requested that we clarify
that the supplier standard in
§ 424.57(c)(27) does not preclude
suppliers from subcontracting the pickup and delivery of liquid and gaseous
oxygen cylinders.
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
Response: It is our intention to ensure
that oxygen suppliers promote quality
in the furnishing of oxygen or oxygenrelated equipment, and, in doing so,
protect Medicare beneficiaries against
substandard product(s) or poor service.
The pick-up and delivery of liquid and
gaseous oxygen cylinders does not
interfere with our intentions for this
provision. Therefore, oxygen suppliers
may continue to subcontract the pick-up
and delivery of oxygen and oxygenrelated products.
Comment: A commenter stated that
there is confusion regarding who needs
to be licensed for specific services and
believes the provisions in
§ 424.57(c)(27) needs greater specificity
and detail.
Response: We appreciate this
comment and have revised
§ 424.57(c)(27) to address this concern.
We have clarified in this section that
DMEPOS suppliers are responsible for
knowing which licenses are required for
the DMEPOS that they supply.
Comment: One commenter
interpreted the proposed rule as
requiring an oxygen supplier to get their
oxygen from an in-State licensed oxygen
supplier.
Response: This final rule will require
licensed oxygen suppliers to get their
oxygen and oxygen-related equipment
from other licensed or State-certified
oxygen suppliers. However, if an oxygen
supplier’s physical location is in a State
that does not require oxygen licensure
or certification, then the oxygen
supplier is not required to get its oxygen
or oxygen-related equipment from other
licensed oxygen suppliers. It is not our
intention to restrict Medicare
beneficiaries’ oxygen supplier choices.
Comment: One commenter
interpreted this standard as requiring an
in-State oxygen license for out-of-State
suppliers and believes this limits access
for Medicare beneficiaries.
Response: We do not require oxygen
licensure or certification for oxygen
suppliers whose physical locations are
in States that do not require oxygen
licensure or certification. However, this
provision does restrict unlicensed
oxygen suppliers from supplying
oxygen and oxygen-related equipment
to oxygen suppliers whose physical
locations are in States that require
oxygen licensure or certification.
Comment: A commenter suggested
adding ‘‘if applicable’’ to this provision
because not all States license oxygen
suppliers.
Response: We agree and will revise
§ 424.57(c)(27) to incorporate language
regarding applicability to States that
license oxygen suppliers.
PO 00000
Frm 00034
Fmt 4700
Sfmt 4700
Comment: One commenter
recommended that we incorporate the
proposed standard in § 424.57(c)(27)
into the revised supplier standard in
§ 424.57(c)(1).
Response: We disagree with this
commenter and have adopted a new
supplier standard in § 424.57(c)(27).
2. Ordering and Referring
Documentation
In § 424.57(c)(28), we proposed a new
supplier standard that states that the
supplier is required to maintain
ordering and referring documentation,
including the National Provider
Identifier, received from a physician,
nurse practitioner, physician assistant,
clinical social worker, or certified nurse
midwife, for 7 years after the claim has
been paid.
Comment: One commenter stated that
it would be more practical and
reasonable to base any records retention
policy on the date of service and
lengthen the retention period to 10
years, which is the guideline used by
many in the industry. This commenter
stated that this change would capture
CMS’ concerns about availability of
records and cause fewer disruptions to
the supplier recordkeeping practices.
Another commenter believes that record
retention should mirror that of industry
or State standards such as the State
Board of Pharmacy which is typically 3
years.
Response: We appreciate the
commenter’ suggestions. However with
the enactment of section of 6406(a) of
the ACA, we published an interim final
rule with comment in the May 5, 2010
Federal Register (75 FR 24437), which
established 7 year retention period
based on the date of service in
§ 424.516(f). Moreover, we believe that
this retention policy is consistent with
the policy established at § 424.516(f) in
the November 19, 2008 final rule (73 FR
69726) entitled ‘‘Medicare Program;
Payment Policies Under the Physician
Fee Schedule and Other Revisions to
Part B for CY2009; E-Prescribing
Exemption for Computer-Generated
Facsimile Transmissions; and Payment
for Certain Durable Medical Equipment,
Prosthetics, Orthotics and Supplies
(DMEPOS)’’. Finally, in § 424.57(c)(28),
we establish that suppliers are required
to maintain ordering and referring
documentation consistent with the
provisions found in § 424.516(f).
Comment: One commenter stated that
it would be more practical and
reasonable to base any records retention
policy on the date of service.
Response: We concur with this
commenter and have revised this
supplier standard to reflect that records
E:\FR\FM\27AUR1.SGM
27AUR1
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
should be based on the date of service
and not the date of payment.
Comment: One commenter is
concerned about why CMS would
develop a supplier safeguard mandating
records retention based upon the date
the claim was paid when all business
transactions are based upon the date of
service or date equipment was provided.
The addition of a new date would
require systems modification just for
managing records and the purge
process.
Response: As stated previously, we
have revised this standard to base any
records retention policy on the date of
service.
Comment: Some commenters stated
that the Health Insurance Portability
and Accountability Act of 1996 (HIPAA)
(Pub. L. 104–191) and State laws govern
the manner in which medical records
need to be kept and urged CMS to
retract the new standard in
§ 424.57(c)(28).
Response: The HIPAA record
retention policy codified at 45 CFR
164.530 relates to a covered entities
privacy policies and procedures (for
example, administrative records of
complaints, notices, and other
administrative actions or procedures);
and therefore, does not preclude us from
establishing a documentation retention
standard. In addition, since Medicare is
a Federal program, it is not subject to
State law. We note that section 6406(a)
of the ACA (Pub. L. 111–148) amends
section 1842(h) of the Act by adding a
new paragraph (9) which states the
following:
WReier-Aviles on DSKGBLS3C1PROD with RULES
The Secretary may revoke enrollment, for
a period of not more than one year for each
act, for a physician or supplier under section
1866(j) if such physician or supplier fails to
maintain and, upon request of the Secretary,
provide access to documentation relating to
written orders or requests for payment for
durable medical equipment, certifications for
home health services, or referrals for other
items or services written or ordered by such
physician or supplier under this title, as
specified by the Secretary.
We also note that section 6406(d) of
ACA specifies that ‘‘[t]he effective date
of this provision shall apply to orders,
certifications and referrals made on or
after January 1, 2010.’’ Therefore, we
believe that finalization of our proposed
record retention requirements at
§ 424.57(c)(28) is consistent with the
section 6406(a) of ACA requirement.
3. Prohibition on Sharing of a Practice
Location
In § 424.57(c)(29), we proposed a new
standard that specifies that the supplier
is prohibited from sharing a practice
location with another Medicare
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
supplier. In addition, we solicited
comments on whether we should
establish an exception to this space
sharing proposal for physicians and
nonphysician practitioners and the
circumstances which warrant an
exception since we are aware that
physicians and other licensed
nonphysician practitioners may obtain
their own DMEPOS supplier number
and furnish DMEPOS from their office.
Comment: One commenter stated that
the proposed standard is too restrictive
and could discourage suppliers from
forming networks under the competitive
rules and urged CMS to retract the new
standard in § 424.57(c)(29).
Response: We do not believe that the
new standard will restrict the ability of
suppliers to form networks for the
purpose of competitive bidding.
Comment: Several commenters
requested that we clarify whether a
‘‘practice location’’ is limited to physical
space or whether it also encompasses
equipment or staff and requests
clarification of the definition of the
terms ‘‘sharing’’ and ‘‘practice location.’’
Response: DMEPOS suppliers list the
practice location in Section 4 of the
Medicare enrollment application (CMS–
855S). For the purposes of this standard,
sharing a practice location refers to
sharing of the physical location as
described on the CMS–855S. In general,
the practice location is the physical
space where a DMEPOS supplier
operates his or her business and meets
with customers and potential customers.
Comment: One commenter requested
that we clarify that the enrolled practice
location does not include a warehouse,
storage facility, or repair facility.
Response: As stated previously, a
DMEPOS supplier identifies the practice
location in Section 4 of the CMS–855
and is a place where a DMEPOS
supplier operates his or her business
and meets with customers and potential
customers.
Comment: Several commenters
requested that we clarify that the space
sharing provision in § 424.57(c)(29) is
not intended to preclude a physician or
licensed health professional (who is also
recognized as a DMEPOS supplier by
Medicare) from furnishing both
DMEPOS products and professional
services to his or her patients in the
same practice location.
Response: We appreciate this
comment and have established an
exception to this standard for
physicians and NPPs as defined in the
statute. Under section 1842(b)(18)(C) of
the Act, physical and occupational
therapists may operate as a DMEPOS
supplier, as well as a licensed
professional at the same practice
PO 00000
Frm 00035
Fmt 4700
Sfmt 4700
52641
location if these suppliers are furnishing
DMEPOS to their own patients as part
of professional service.
Comment: One commenter stated that
if any limitation on sharing practice
locations is put in place that we should,
at most, formalize the NSCs practice of
prohibiting multiple NSC supplier
numbers at a single address.
Response: While we have established
a limited number of exceptions to the
prohibition of sharing a practice
location, we agree that the NSC should
not convey billing privileges to
suppliers who are not in compliance
with the provisions of this final rule.
Moreover, with the implementation of
the National Provider Identifier (NPI), a
DMEPOS supplier must obtain a NPI for
each practice location, unless the
supplier is a sole proprietorship.
Accordingly, we believe that this policy
is consistent with current National
Supplier Clearinghouse operational
policy and the provisions for issuing an
NPI.
Comment: One commenter agreed
with the statement in the preamble of
the proposed rule that stated, ‘‘We do
not believe that legitimate DMEPOS
suppliers routinely share practice
locations with another Medicare
supplier.’’
Response: We appreciate this
comment and continue to believe that
legitimate businesses do not share
practice locations with competitors.
Comment: One commenter stated that
if a space sharing agreement passes
under both the Anti-kickback statute
and the Stark statute and regulations,
then they do not believe such
arrangements should be automatically
prohibited by a supplier standard.
Response: We disagree with this
commenter. While the statutory and
regulatory provisions referenced
previously are intended to prohibit
specific practices, these provisions do
not address the full range of problems
that occur when DMEPOS suppliers are
commingling practice locations. The
Anti-kickback statute, the Stark statute,
and our regulations are separate
authorities and do not preclude us from
establishing additional DMEPOS
supplier standards. In addition, we do
not believe that legitimate DMEPOS
suppliers share inventory, staffing or a
practice location with a competing
DMEPOS supplier.
Comment: Several commenters
recommended that physical therapists
(PTs) be exempt from this provision
because it would place an undue burden
on the patient to purchase the limited
DME items offered in the PT office at
another location—especially for
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
52642
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
pediatric PTs or those located in rural
areas.
Response: As stated previously, we
are establishing an exception for
physical and occupational therapists
from the provision in § 424.57(c)(29).
Comment: Several commenters stated
that there should be an exception to this
provision when both businesses are
owned by the same person or entity or
the DME supplier is a separate unit
located within or owned by a larger
health care facility such as a hospital.
Other commenters stated there should
be an exception to this provision when
a pharmacy is operating within a Statelicensed health center because of the
burden separate locations would put on
the patients.
Response: We disagree with
commenters who stated that we should
establish an exception based solely on
ownership. Moreover, unless the owner
of DMEPOS supplier is a sole
proprietorship, DMEPOS suppliers are
required to obtain a unique National
Provider Identifier for each practice
location. Accordingly, unless a
DMEPOS supplier has satisfied an
exception under § 424.57(c)(29), we do
not believe that an owner should be
permitted to establish a sole
proprietorship and an organizational
entity at the same practice location.
Similarly, we do not believe that the
same owner should be able to obtain
separate Medicare billing privileges for
DMEPOS suppliers at the same practice
location found on the Medicare
enrollment application. As stated
previously, we do not believe that
legitimate businesses share practice
locations with competitors. However,
we agree with the commenters who
stated that there should be an
exemption when the entity or DME
supplier is a separate unit located
within or owned by a larger facility.
Therefore, we have established
exceptions to the sharing of space
limitation found in § 424.57(c)(29). In
§ 424.57(c)(29)(ii)(C), we have
established an exception for DMEPOS
suppliers that have a practice location
within a Medicare provider that is
subject to the requirements specified in
42 CFR 489.2(b). This exception will
allow a hospital, home health agency
(HHA), skilled-nursing facility (SNF), or
other Part A provider that is enrolled in
Medicare to co-locate with a DMEPOS
supplier that is owned by that Part A
provider and is a separate unit. It is
important to note that these DMEPOS
suppliers while owned by the Part A
provider must still meet all of the other
DMEPOS supplier standards in § 424.57
to obtain and maintain Medicare billing
privileges.
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
Comment: One commenter asked if
two entities, with two different ‘‘Doing
Business As’’ (DBA) names are owned
by the same parent company would they
be prohibited from having a common
location under § 424.57(c)(29).
Response: As stated previously, we
have established certain exceptions to
this provision. However, we do not
believe that it is a common practice to
establish multiple DBAs at the same
practice location. Accordingly, we
believe that two different DBAs that are
owned by the same parent company
would be prohibited from sharing a
practice location under this provision.
Comment: One commenter believes
the regulation text does not properly
convey the intent of the language in the
preamble and will result in additional
micromanagement of DMEPOS
suppliers by CMS.
Response: We believe that the
provisions of this final rule and the
regulation text are consistent. In
addition, we believe that the provisions
as adopted allow CMS or the NSC to
ensure that DMEPOS suppliers are
operating in accordance with
established business practices used by
legitimate companies. As stated
previously, we do not believe that
legitimate DMEPOS suppliers share
inventory, staffing or operational space
with their competitors.
Comment: One commenter believes
that an orthotic and prosthetic facility
should be allowed to share space with
complementary, but not competing
businesses that may already have a
Medicare supplier number, specifically
physicians and physical therapy offices.
Response: We disagree with this
commenter. While we have established
an exception to § 424.57(c)(29) for
physicians, NPPs, and physical and
occupational therapists who are
furnishing items to their own patients as
part of their professional service, we do
not believe that a similar exception
should be established for orthotic and
prosthetic facilities or personnel
because they are not individual
practitioners who are furnishing items
to their own patients as part of their
professional service. The facilities in
question would be sharing space with
another supplier whereas the exceptions
noted are supplying their own patients
as part of their service.
Comment: Several commenters
questioned whether the supplier can
have an office in the same building
where other hospital-owned Medicare
suppliers (outpatient pharmacy,
physician groups) are located if it is
hospital-owned.
PO 00000
Frm 00036
Fmt 4700
Sfmt 4700
Response: We agree that a DMEPOS
supplier may be enrolled within the
same building owned by a hospital.
Comment: One commenter does not
believe co-existing in an office space
jeopardizes quality supplier standards.
Response: We disagree because we
have found that unrelated business
entities that share the same practice
location often provide poor quality care
or, in some case, are associated with
fraudulent businesses or do not exist.
Comment: One commenter agrees
with CMS’ proposal that nonphysician
DMEPOS suppliers should not share a
practice location with another Medicare
supplier, especially if that other
Medicare supplier is a possible referral
source.
Response: We appreciate the support
for our provision regarding the sharing
of space and further clarify that the
Anti-kickback statute, the Stark Statute,
and our regulations are separate
authorities apart from the sharing of
space provisions adopted within this
final rule.
Comment: Several commenters
requested that we not create exceptions
to this provision for physicians and
other licensed providers to share space
as it is a bad idea that creates
inconsistent application of the
regulations. In addition, making
physicians discontinue distributing
DME from their offices is good and the
physician, orthotist/prosthetist, and
physical therapist should have no
financial relationship to ensure true
medical necessity.
Response: We believe that we can
consistently apply the regulations and
allow for reasonable exceptions.
Moreover, we believe that physicians
can furnish DMEPOS to their own
patients as part of professional service.
In addition, in many cases, a physician
furnishing DMEPOS to their own
patients can benefit those patients in
terms of convenience and continuity of
care.
Comment: One commenter asks if this
standard would apply in the
circumstance where the business owner
owns a pharmacy and a separate
DMEPOS company with 2 different
supplier Medicare numbers sharing the
same location for retail sales (note—
both businesses have the same stock
holders and are held by a separate
holding company).
Response: We believe that the
scenario described is prohibited under
the provisions of this final regulation.
Comment: One commenter suggested
that an exception to this provision be
made for those physicians/NPPs that
supply blood glucose monitoring
devices to their patients.
E:\FR\FM\27AUR1.SGM
27AUR1
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
WReier-Aviles on DSKGBLS3C1PROD with RULES
Response: We appreciate this
comment and as stated previously, we
are adopting an exception to the
prohibition on space sharing for
physician, NPPs, and physical and
occupational therapists.
4. Hours of Operation
In § 424.57(c)(30), we proposed a new
supplier standard that would require a
DMEPOS supplier to be open to the
public a minimum of 30 hours per
week, except for those DMEPOS
suppliers who are working with custommade orthotics and prosthetics.
Comment: Several commenters
requested that physical therapy
practices be exempt from posting office
hours because this would limit the
services available to the Medicare
patients.
Response: We believe that all
DMEPOS suppliers should have posted
hours of operation.
Comment: A commenter stated that it
would be burdensome for hospitals or
health systems that owned or controlled
DMEPOS suppliers to display hours of
operation and that the proposed
standard is unnecessary since the
implementation of mandatory
accreditation.
Response: In § 424.57(c)(8), we
already require that DMEPOS suppliers,
including those owned or controlled by
hospitals and health systems, to
maintain a visible sign and post their
hours of operation. Accordingly, we
believe that we are clarifying an existing
NSC practice by adopting this revised
standard. Moreover, since accreditation
primarily focuses on patient care, it
does not directly address the
verification of this existing supplier
standard.
Comment: One commenter believes
the requirement that suppliers maintain
a physical facility that is staffed at all
times with posted working hours is
most beneficial.
Response: We appreciate this
comment and have adopted a minimum
number of posted hours of operation for
DMEPOS suppliers in § 424.57(c)(30).
Comment: Several commenters stated
that it is a widespread practice among
DMEPOS suppliers—large and small—
to have part-time or ‘‘by appointment
only’’ hours for some locations,
especially in rural areas, and asked that
we reconsider the new supplier
standard in § 424.57(c)(30) which
requires suppliers to remain open to the
public for a minimum of 30 hours a
week. Some commenters believe
remaining at the facility for 30 hours per
week would leave no time for item
delivery and proposed that CMS
consider the requirement met as long as
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
the hours are posted and the supplier is
open during those hours.
Response: We believe that DMEPOS
suppliers must be open to the public a
minimum number of hours to ensure
patient access to services. After a careful
review of these comments, we continue
to believe that DMEPOS suppliers must
be open and available to the public a
minimum of 30 hours per week. We
believe that establishing a minimum
number of hours is in the best interest
of the Medicare program and Medicare
patients, especially for those who are
disabled or with limited means of
transportation.
Comment: Several commenters stated
that they do not believe that CMS has
the authority or business expertise to
dictate the number of hours a DMEPOS
supplier should operate to be
considered legitimate when this would
be determined based on the needs of the
customer base.
Response: We believe that section
1834(j)(1)(B) of the Act gives the
Secretary the authority to implement
additional supplier standards. We
maintain that the requirement that a
DMEPOS supplier is open a minimum
number of hours help to ensure that it
is engaged in furnishing DMEPOS to
Medicare beneficiaries. In addition, we
believe that this requirement also may
help increase access to care for
Medicare beneficiaries.
Comment: One commenter
recommended that we consider
permitting flexibility in the hours of
operation so long as they are clearly
posted and deviations to the posted
hours are noted with a specific return
time.
Response: We disagree with this
commenter. It is essential for our
Medicare beneficiaries to have access to
suppliers during regularly scheduled
hours. Medicare beneficiaries should
not be advised that the supplier has
temporarily changed their hours once
they have made the effort to visit the
supplier. Moreover, allowing DMEPOS
suppliers to constantly change their
posted hours of operation would make
it virtually impossible for us to
determine if a supplier is actually in
operation. While we recognize that
emergencies do occur, it is the
responsibility of the DMEPOS supplier
to establish staff contingencies to ensure
that their business remains open to the
public in spite of a personal emergency.
Comment: Several commenters
recommended that we establish an
exception to the supplier standard in
§ 424.57(c)(30) for physicians, physical
therapists, and other licensed health
professionals holding DMEPOS
suppliers numbers, especially when
PO 00000
Frm 00037
Fmt 4700
Sfmt 4700
52643
DMEPOS supplies makes up such a
small portion of the practice.
Response: We appreciate these
comments and have added an exception
to this supplier standard for physicians
and licensed non-physician
practitioners, including physical and
occupational therapists, that only
furnish DMEPOS supplies to their own
patients to § 424.57(c)(30).
Comment: Several commenters stated
that it is not economically feasible for a
small one person supplier to be staff
during all posted hours of operations
because they often make house calls.
Response: While we understand the
concerns of small suppliers, we believe
that Medicare beneficiaries and the NSC
should be able to have access to the
supplier at regularly posted hours. Also,
as previously noted, we have
established exceptions for physicians,
NPPs, and certain other suppliers.
Comment: One commenter stated that
this requirement does not allow a sole
proprietor, being the only certified fitter
as well as the owner, to be sick, go on
vacation, or have a personal emergency
without violating Medicare standards.
Response: We agree and have adopted
an exception to this provision for
suppliers working with custom-made
orthotics and prosthetics.
Comment: Several commenters stated
that there may be episodic instances
where DMEPOS suppliers may
legitimately not be able to be open for
30 hours per week including inclement
weather conditions, staffing shortages as
the result of labor disputes, staff
illnesses or holiday periods, and various
other unusual occurrences or natural
disasters that would prohibit a supplier
from being open 30 hours in a particular
week.
Response: We recognize that
unforeseen emergencies do occur that
would require a supplier to make
temporary changes to scheduled hours.
The NSC will take these circumstances
into account. However, we believe that
DMEPOS suppliers should adhere to its
posted hours and should develop
contingencies to remain open when
personal emergencies or when staffing
issues occur.
Comment: One commenter
recommended that CMS implement an
exception for physical therapists for the
posting of office hours.
Response: We disagree with this
commenter. We believe a physical
therapist enrolled as a DMEPOS
supplier must post its hours of
operation for beneficiaries so that CMS
or its agents can perform site visits.
However, as discussed previously, we
note that we have established an
exception for physical therapists in
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
52644
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
certain circumstances to the supplier
standard of the 30 hours minimum
requirement.
Comment: One commenter suggested
the language describing the proposed
change at § 424.57(c)(8) be changed from
‘‘would deny’’ to ‘‘may deny’’ to allow for
situations where the NSC or its agents
are unable to perform a site visit during
a supplier’s posted business hours.
Response: While we understand this
comment, we do not believe that the
change is needed.
Comment: One commenter asked for
clarification of what constitutes custom
fabricated orthotics and prosthetics. The
commenter questioned whether it is the
definition from the competitive bidding
document or the explanation of each
product in the HCPCS codes.
Response: For purposes of the
regulatory provision, orthotics and
prosthetics is defined in the HCPCS
codes related to each product and as
described in the DMEPOS quality
standards.
Comment: One commenter suggested
an alternative to the proposed provision
could be for the entire practice (all
office locations collectively), to be open
a minimum number of hours which
would allow for satellite offices in
remote areas, as well as accommodating
those therapists in private practice for
the purpose of limiting their work
hours. The commenter considers 20
hours a week to be reasonable.
Response: Each DMEPOS supplier
location is separately enrolled, and
therefore, each location must meet all
the required supplier standards in
§ 424.57.
Comment: A commenter stated that
requiring DMEPOS suppliers, except
suppliers of prosthetics and orthotics, to
be open to the public for at least 30
hours a week is unnecessary for
supplier’s facilities that are not intended
for beneficiary access and that this
proposed standard blurs the distinction
between a classic retail establishment
and a service facility dedicated to the
provision of supplies and equipment to
patients in their homes. In addition, the
commenter requests that CMS consider
different business models for supplier
standards, and let the beneficiaries and
their physicians decide what model may
work best for them.
Response: We do not believe these
arrangements are always in the best
interest of the patient. We believe that
all enrolled DMEPOS suppliers, except
suppliers of prosthetics and orthotics,
should maintain a minimum number of
hours open to the public. This will
ensure that the DMEPOS supplier is
operational and allows CMS, the NSC or
agents of CMS or the NSC to conduct
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
unannounced site visits to ensure
compliance with the standards set forth
at § 424.57.
Comment: One commenter believes
the weekly hourly requirement severely
limits the ability to provide services in
small towns, because it does not allow
for the use of ‘‘limited business hour’’
satellite facilities.
Response: After careful review of this
standard, we have determined that
requiring a DME supplier to be open
and available to the public no less than
30 hours per week is in the best interest
of the patient, especially for those who
are disabled or with limited means of
transportation.
5. Tax Delinquency
In § 424.57(c)(31), we proposed
adding a new supplier standard that
specified that a DMEPOS supplier could
not have Internal Revenue Service (IRS)
or a State taxing authority tax
delinquency. We also proposed to
define a ‘‘tax delinquency’’ as meaning
an amount of money owed to the United
States or a State: A conviction or civil
judgment for tax evasion, a criminal or
civil charge of tax evasion, or the filing
of a tax lien.
With the enactment of section 189 of
the Medicare Improvements for Patients
and Providers Act (MIPPA) (Pub. L.
110–275) on July 15, 2008, we are
deferring the implementation of this
proposal while we continue to review
the public comments received on this
provision and we will consider
finalizing this provision in a future
rulemaking effort if we deem it
necessary. Accordingly, we are not
adopting this proposed supplier
standard in this rule and have removed
the paperwork burden associated with
this provision.
6. Medicare Overpayment
In § 424.57(d), we proposed to
redesignate the current text as paragraph
(d)(1) and proposed adding a new
paragraph that specified that ‘‘CMS, the
NSC, or CMS designated contractor
establishes a Medicare overpayment
from the date of an adverse legal action
or felony conviction (including felony
convictions within the 10 years
preceding enrollment or revalidation of
enrollment) that precludes payment.’’ In
addition, we proposed that any
overpayment assessed by CMS or its
designated contractor due to a failure to
report this information would follow the
existing rules governing Medicare
overpayments set forth at § 405.350
et seq. The underlying basis to report
‘‘adverse legal actions’’ to the NSC are
found in § 424.530 and § 424.535, which
state the provisions for denial of
PO 00000
Frm 00038
Fmt 4700
Sfmt 4700
enrollment and the revocation of billing
privileges.
Comment: One commenter stated that
the term ‘‘adverse legal action’’ was
vague and requested that we clarify or
eliminate the authority regarding
overpayments resulting from adverse
legal actions in § 424.57(d). The
commenter stated that no notice was
provided regarding the types of events
that would trigger an overpayment
collection. This commenter further
stated that before this regulatory
provision could be finalized, more
fulsome notice must be given so that
stakeholders can submit meaningful
comments.
Response: We agree and have revised
§ 424.57(a) to add a definition for the
term ‘‘final adverse action’’ as meaning
one or more of the following actions: (1)
A Medicare-imposed revocation of any
Medicare billing number; (2) suspension
or revocation of a license to provide
health care by any State licensing
authority; (3) revocation or suspension
of accreditation; (4) a conviction of a
Federal or State felony offense (as
defined in § 424.535(a)(3)(i)) within the
last 10 years preceding enrollment,
revalidation, or re-enrollment; or (5) an
exclusion or debarment from
participation in a Federal or State health
care program. This definition is
narrower than the list of final adverse
actions contained in Section 3 of the
CMS–855S which was published on
March 23, 2009. In fact, we limited the
definition of ‘‘final adverse action’’ in
this rule to those actions that currently
serve as a basis for CMS to revoke a
supplier’s Medicare billing privileges
under § 424.535(a). If a final adverse
action has been imposed upon a
supplier, then that supplier would not
be eligible to maintain Medicare billing
privileges from the date of a final
adverse action. This provision provides
CMS or its contractors with the
discretion to establish an overpayment
determination (as defined in § 405.350)
for all Medicare items and services
furnished from the date of the final
adverse action. CMS or our contractors
may reopen all claims paid to the
supplier on or after the date of the final
adverse action that had been imposed
upon that supplier. Moreover, suppliers
who are assessed overpayments under
this provision may appeal these
determinations in accordance with the
Medicare claims appeal procedures set
forth in § 405.900 through § 405.1140.
Comment: One commenter believes
the requirement to notify the NSC of
changes is too burdensome.
Response: We appreciate the
commenters’ concerns. However, we
maintain that it is necessary to require
E:\FR\FM\27AUR1.SGM
27AUR1
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
DMEPOS suppliers to notify the NSC of
a final adverse action or other reportable
change, including change of location,
change of ownership (including
authorized and delegated officials)
within 30 days to mitigate the possible
impacts associated with these types of
changes.
7. Notification of Change in Hours
Operation
In § 424.57(c)(32), we are proposing
that each supplier must report changes
in hours of operation to the NSC 15
calendar days prior to the proposed
change. The burden associated with this
requirement is the time and effort
associated with notifying the NSC of the
change in hours of operation.
We are not finalizing this provision.
In section V. of this final rule, we
respond to the comment received on the
information collection requirement
associated with this provision.
WReier-Aviles on DSKGBLS3C1PROD with RULES
8. Other Issues
The following is our response to a
comment that was not on a proposal
included in this proposed rule:
Comment: One commenter requested
that we clarify that § 424.57(c)(26) was
reserved for the proposed DME surety
bond standard.
Response: We note that
§ 424.57(c)(26) was reserved for the
proposed DME surety bond standard.
We also note that the proposed
provision at § 424.57(c)(26) was
finalized in the January 2, 2009 final
rule (74 FR 166) entitled ‘‘Medicare
Program; Surety Bond Requirement for
Suppliers of Durable Medical
Equipment, Prosthetics, Orthotics, and
Supplies (DMEPOS).’’
IV. Provisions of the Final Regulations
This final rule finalizes the provisions
of the proposed rule with the following
exceptions:
• In § 424.57(a), we modified our
proposal as follows:
++ Added the definition for the term
‘‘direct solicitation.’’
++ Revised the definition for the term
‘‘final adverse action’’. We note that the
definition for this term was added by a
January 2, 2009 final rule (74 FR 166).
We revised this term by—(1) replacing
the semicolons at the end of paragraphs
(i) through (iv) with periods; (2) revising
paragraph (iii) by adding the phrase ‘‘as
stated § 424.58’’ to the end of the
paragraph; and (3) revising paragraph
(iv) by removing the word ‘‘or’’ from the
end of the paragraph.
• In § 424.57(c)(1), we made the
following modifications to our proposal:
++ Added language to clarify that a
DMEPOS supplier must be licensed to
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
provide the licensed service(s) and
cannot contract with an individual or
entity to provide the licensed service(s).
++ Added language to clarify that a
licensed professional can be a part-time
or full-time employee.
• In § 424.57(c)(7), we modified our
proposal as follows:
++ Revised the proposed
introductory text of paragraph (c)(7).
The language regarding the space for
storing records and retaining ordering
and referring documentation was
modified and redesignated as
paragraphs (c)(7)(i)(E) and (F),
respectively.
++ Added a new paragraph
(c)(7)(i)(A) that specifies a minimum
square footage requirement and an
exception to the minimum square
footage requirement for State-licensed
orthotic and prosthetic personnel
providing custom fabricated orthotics or
prosthetics in private practice.
++ Modified and redesignated
proposed paragraphs (c)(7)(i) through
(c)(7)(iii) as paragraphs (c)(7)(i)(B)
through (c)(7)(i)(D).
++ Redesignated paragraph (c)(7)(iv)
as paragraph (c)(7)(ii).
++ Added a new paragraph (c)(7)(iii)
that specifies that an appropriate site
may be the centralized location for all
of the business records and ordering and
referring documentation of a multisite
supplier.
• In § 424.57(c)(9), we made technical
and clarifying changes.
• In § 424.57(c)(10), we are not
finalizing this proposed provision in
this final regulation.
• In § 424.57(c)(11), we added a
definition of direct solicitation in
§ 424.57(a).
• In § 424.57(c)(12), we are not
finalizing this proposed provision in
this final rule.
• In § 424.57(c)(27), we are adopting
this provision as proposed.
• In § 424.57(c)(28), we adopting the
provision established in § 424.516(f).
• In § 424.57(c)(29), we added an
exception to our requirements on the
prohibition of sharing a practice
location in paragraph (c)(29)(ii).
• In § 424.57(c)(30), we added
exceptions for DMEPOS suppliers who
are working with custom-made orthotics
and prosthetics and physicians,
nonphysician practitioners, and
physical and occupational therapists.
• In § 424.57(c)(31), we are not
finalizing this proposed provision in
this final rule.
• In § 424.57(c)(32), we are not
finalizing this proposed revision in this
final rule. Accordingly, we have
withdrawn the information collection
requirement request associated with this
provision.
PO 00000
Frm 00039
Fmt 4700
Sfmt 4700
52645
• In § 424.57(e) (which was proposed
as § 424.57(d)), we are modifying our
proposal with a change to the effective
date of date of revocation. (See the
Surety Bond final rule in the March 27,
2009 Federal Register (74 FR 13345)). In
order to be consistent with our
regulations at § 424.535(g), we are
extending the effective date of
revocation from 15 to 30 days after
notification of the revocation.
V. Collection of Information
Requirements
Under the Paperwork Reduction Act
of 1995 (PRA), agencies are required to
provide a 30-day notice in the Federal
Register and solicit public comment
before a collection of information
requirement is submitted to the Office of
Management and Budget (OMB) for
review and approval. In order to fairly
evaluate whether an information
collection should be approved by OMB,
section 3506(c)(2)(A) of the PRA
requires that we solicit comments on the
following issues:
• Whether the information collection
is necessary and useful to carry out the
proper functions of the agency;
• The accuracy of the agency’s
estimate of the information collection
burden;
• The quality, utility, and clarity of
the information to be collected; and
• Recommendations to minimize the
information collection burden on the
affected public, including automated
collection techniques.
The following is a discussion of the
provisions, as stated in section III. of
this final rule, that contain information
collection requirements.
The provision at § 424.57(c)(1) states
that a supplier must operate its own
business and furnish Medicare–covered
items in compliance with all applicable
Federal and State licensure and
regulatory requirements. The purpose of
this standard is to ensure that DMEPOS
suppliers obtain and maintain the
necessary State licenses required to
furnish services provided to Medicare
beneficiaries. While there is burden
associated with complying with this
standard, we believe it is exempt from
the PRA as stated in 5 CFR 1320.3(b)(3).
A collection of information conducted
or sponsored by a Federal agency that is
also conducted or sponsored by a unit
of State, local, or tribal government is
presumed to impose a Federal burden
except to the extent that the agency
shows that such State, local, or tribal
requirement would be imposed even in
the absence of a Federal requirement. In
addition, we believe the burden
associated with the maintenance of the
required documentation is exempt from
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
52646
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
the PRA as stated in 5 CFR 1320.3(b)(2),
to the extent that the time, effort, and
financial resources necessary to comply
with collection of information that
would be incurred by persons in the
normal course of their activities.
Maintaining State license
documentation is part of usual and
customary business practices.
Proposed § 424.57(c)(10)(iii) stated
that with respect to liability insurance,
it was the responsibility of the DMEPOS
supplier to, ‘‘promptly notify the NSC in
writing of any policy changes or
cancellations.’’ The burden associated
with this proposed requirement was the
time and effort associated with drafting
and submitting notification to the NSC
of any policy changes or cancellations.
However, we have decided not to
finalize this requirement in this final
rule and therefore will not be submitting
an information collection request to
OMB for its review and approval.
Proposed § 424.57(c)(12) stated that a
supplier, ‘‘[m]ust be responsible for the
delivery of Medicare-covered items to
beneficiaries and maintain proof of
delivery.’’ In addition, the supplier
must, ‘‘[d]ocument that it or another
qualified party has at an appropriate
time, provided beneficiaries with
information and instructions on how to
use the Medicare-covered items safely
and effectively.’’ The burden associated
with this section is the time and effort
required to: Document the delivery of
the Medicare-covered item; document
the provision of information or
instructions to the beneficiary by the
supplier itself or another qualified
party; maintain the documentation of
delivery of the Medicare-covered items
and the necessary information and
instructions. While the burden
associated with the aforementioned
proposed requirements is subject to the
PRA, we have decided not to finalize
these requirements in this final rule and
therefore will not be submitting an
information collection request to OMB
for its review and approval.
Proposed § 424.57(c)(12)(ii) specified
that a supplier must furnish information
to beneficiaries at the time of delivery
of items on how the beneficiary can
contact the supplier by telephone. The
burden associated with complying with
the standard is the time and effort
required for the supplier to provide its
contact information to beneficiary at the
time of delivery of the Medicare-covered
item(s). While the burden associated
with the aforementioned proposed
requirement is subject to the PRA, CMS
has decided not to finalize this
requirement in this final rule and
therefore will not be submitting an
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
information collection request to OMB
for its review and approval.
The provision at § 424.57(c)(28)
discusses a recordkeeping requirement.
This provision states that suppliers are
required to maintain ordering and
referring documentation, including NPI,
received from a physician or eligible
professional for 7 years from the date of
service. Based on public comment and
the provisions established in prior
rulemaking documents, we revised this
provision for record retention
requirement from 7 years after a claim
is reimbursed to 7 years from the date
of service.
The burden associated with this
requirement is the time and effort
necessary for a supplier to file and
maintain ordering and referring
documentation from the previously
stated list of providers. While this
requirement is subject to the PRA, the
associated burden is exempt under 5
CFR 1320.3(b)(2), to the extent that the
time, effort, and financial resources
necessary to comply with collection of
information that would be incurred by
persons in the normal course of their
activities. Maintaining ordering and
referring documentation is a usual and
customary business practice.
Proposed § 424.57(c)(32), stated that
each supplier must report changes in
hours of operation to the NSC 15
calendar days prior to the proposed
change. The burden associated with this
requirement is the time and effort
associated with notifying the NSC of the
change in hours of operation. We
estimated that 1,000 suppliers will be
subject to this requirement. The
estimated time required to report the
information to the NSC is 10 minutes.
The estimated total annual burden
associated with this requirement is 167
hours. We received a public comment
regarding the burden assessment for the
information collection requirement
contained in § 424.57(c)(32).
Comment: One commenter stated that
there is little gained by imposing such
a rigid notification and requests that the
requirement be modified to permit the
supplies to notify the NSC of changes in
operation within 30 calendar days after
the proposed change and that we should
revise the burden estimate associated
with this provision.
Response: We appreciate this
comment and agree that this provision
would increase the paperwork burden
imposed on DMEPOS suppliers.
Accordingly, we are not adopting this
new supplier standard and have
removed the paperwork burden
associated with this provision.
Consistent with supplier standard in
§ 424.57(c)(2), we will continue to
PO 00000
Frm 00040
Fmt 4700
Sfmt 4700
require that DMEPOS suppliers report
changes in operation within 30 calendar
days.
We have submitted a copy of this final
rule to OMB for its review and approval
of the aforementioned information
collection requirements.
VI. Regulatory Impact Statement
We have examined the impacts of this
rule as required by Executive Order
12866 on Regulatory Planning and
review (September 30, 1993), the
Regulatory Flexibility Act (RFA)
(September 19, 1980, Pub. L. 96–354),
section 1102(b) of the Social Security
Act, section 202 of the Unfunded
Mandates Reform Act of 1995 (Pub. L.
104–4), Executive Order 13132 on
Federalism (August 4, 1999), and the
Congressional Review Act (5 U.S.C.
804(2)).
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
if regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety effects, distributive impacts,
and equity). A regulatory impact
analysis (RIA) must be prepared for
major rules with economically
significant effects ($100 million or more
in any 1 year). This rule does not reach
the economic threshold and thus is not
considered a major rule.
To ensure that Medicare is making
correct payments to only legitimate
DMEPOS suppliers, we implemented a
comprehensive payment and enrollment
strategy. This strategy includes
developing and implementing the
statutorily-mandated competitive
bidding program, making revisions to
the National Supplier Clearinghouse
contract, implementing a DMEPOS
demonstration project, and publishing a
proposed rule that would require
DMEPOS suppliers to obtain a surety
bond.
Accordingly, it is essential that we
further develop and implement
administrative and regulatory changes
which prevent unscrupulous DMEPOS
suppliers from enrolling or maintaining
their enrollment in the Medicare
program. To this end, we have
implemented the following
administrative changes and are seeking
comments on mandated DMEPOS surety
bonding requirements.
As part of our administrative change,
we revised the contract with the
National Supplier Clearinghouse (NSC)
in FY 2008 and are currently
recompeting this contract through full
and open competition. The revised
contract requires that the NSC conduct
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
and increase the number of on-site visits
to ensure that DMEPOS suppliers are in
compliance with the provisions in
§ 424.57. We are also expanding the
funding for NSC operations to support
the increased number of site visits.
These expanded measures will help to
ensure that only legitimate DMEPOS
suppliers are enrolled or maintain
enrollment in the Medicare program. In
addition, we announced plans on June
28, 2007, to implement a 2-year
demonstration involving DMEPOS
suppliers. The goal of this initiative is
to strengthen our ability to detect and
prevent fraudulent activity and has
focused specifically on DMEPOS
suppliers in South Florida and the Los
Angeles metropolitan area. Based on the
findings of this initiative, we will
determine if the administrative
processes and procedures used in this
demonstration should be expanded to
other parts of the country.
On August 1, 2007, we published a
proposed rule (72 FR 42001) which
would implement section 4312(a) of the
Balanced Budget Act of 1997 (BBA) by
requiring all Medicare DMEPOS
suppliers to furnish CMS with a surety
bond. The public comment period for
this proposed rule closed on October 1,
2007. As noted previously, we finalized
the surety bond provisions in a final
rule entitled ‘‘Medicare Program; Surety
Bond Requirement for Suppliers of
Durable Medical Equipment,
Prosthetics, Orthotics, and Supplies
(DMEPOS)’’ on January 2, 2009.
Accordingly, while the activities
described previously will promote
compliance with the existing supplier
standards, these activities do not supply
CMS and the NSC with the needed
authority to deny or revoke billing
privileges to those DMEPOS suppliers
that pose a significant risk to the
program. Therefore, we believe that the
provisions of this final rule are essential
in expanding upon and strengthening
the supplier standards in order to
ensure that only legitimate suppliers are
enrolled or maintain enrollment in the
Medicare program.
The RFA requires agencies to analyze
options for regulatory relief for small
businesses. For purposes of the RFA,
small entities include small businesses,
nonprofit organizations, and
government agencies. Most hospitals
and most other providers and suppliers
are small entities, either by nonprofit
status or by having revenues of $7.0 to
$34.5 million in any 1 year. (For details,
see the Small Business Administration’s
Web site at https://sba.gov/idc/groups/
public/documents/sba_homepage/
serv_sstd_tablepdf.pdf (refer to the
620000 series. There are four categories
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
of provider revenues listed, $7.0, $10.0,
$13.5, and $34.5 million or less).
Individuals and States are not included
in the definition of a small entity.
We are not preparing an analysis for
the RFA because we are certifying that
this rule will not have a significant
economic impact on a substantial
number of small entities. We have
determined that the RFA is reasonable
given that the provisions contained in
this final rule are primarily procedural
and do not require DMEPOS suppliers
to incur additional operating costs. We
also believe that the regulatory impact
of this final rule is negligible and not
calculable. We understand that there
may be some additional concerns about
costs associated with a minimum square
footage requirement; however, we
maintain that this final rule would not
have an adverse impact on a significant
number of small entities because we
believe that these suppliers are
operating on standard business practices
and therefore are already in compliance
with these standards. Additionally, we
established a limited time exception for
those entities that do not meet the
minimum square footage requirement
and have entered into a long-term lease
on or before the publication date of this
final rule. Since we believe that a
significant number of small entities
currently meet each of the revised or
new standard, we do not have
information available to calculate the
economic impact of any individual or
combination of proposals would have
on small entities. This final rule would
merely clarify, expand, and update our
current policy in the DMEPOS supplier
standards currently covered in § 424.57.
Therefore, we anticipate a minimal
economic impact, if any, on small
entities.
As of March 2008, there were 113,154
individual DMEPOS suppliers.
However, due to the affiliation of some
DMEPOS suppliers with chains, there
were only approximately 65,984 unique
billing numbers. We believe that
approximately 20 percent of the
DMEPOS suppliers are located in rural
areas.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 604 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
as a hospital that is located outside of
a Metropolitan Statistical Area and has
fewer than 100 beds. We are not
preparing an analysis for section 1102(b)
of the Act because we have determined
PO 00000
Frm 00041
Fmt 4700
Sfmt 4700
52647
that this final rule will not have a
significant impact on the operations of
a substantial number of small rural
hospitals. We understand that a large
number of DMEPOS suppliers fall into
this category, however these provisions
are procedural in nature and we expect
that legitimate DMEPOS suppliers are
already meeting these provisions.
Section 202 of the Unfunded
Mandates Reform Act of 1995 (UMRA)
also requires that agencies assess
anticipated costs and benefits before
issuing any rule that may result in
expenditure in any 1 year by State,
local, or tribal governments, in the
aggregate, or by the private sector, of
$100 million. That threshold is
currently approximately $130 million.
This rule does not mandate
expenditures by State, local, or tribal
governments, in the aggregate, or by the
private sector of $130 million and
therefore no analysis is required.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on State and local
governments, preempts State law, or
otherwise has Federalism implications.
Since this regulation does not impose
any costs on State or local governments,
the requirements of E.O. 13132 are not
applicable.
We anticipate that this rule would
codify certain procedural policies
contained in the Program Integrity
Manual (PIM) that DMEPOS suppliers
already are supposed to adhere to, and
that legitimate DMEPOS suppliers
should already be meeting. By
establishing the standards in this rule,
we are establishing our authority to
deny or revoke the Medicare billing
privileges of DMEPOS suppliers that
have failed to comply with one or more
of these supplier standards.
We have considered alternatives to all
of the provisions; however, only one of
the provisions considered lends itself to
other options. Initially, we considered
establishing a 40 hour requirement for a
DMEPOS supplier’s hours of operation
since most business are open to the
public for a minimum of 40 hours each
week.
To reduce the burden associated with
this provision, but also to establish a
minimum requirement for the hours of
operation, we relaxed the initial 40-hour
requirement to 30 hours per week
because we believe that this is the
minimum amount of time that a
DMEPOS supplier is required to be open
and legitimately operate as a business.
We did not consider the alternative of
not proceeding with the proposed
E:\FR\FM\27AUR1.SGM
27AUR1
52648
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
provisions because we believe that they
are necessary to ensure that only
legitimate DMEPOS suppliers are
enrolling and maintaining enrollment in
the Medicare program.
In accordance with the provisions of
Executive Order 12866, this regulation
was reviewed by the Office of
Management and Budget.
List of Subjects in 42 CFR Part 424
Emergency medical services, Health
facilities, Health professionals,
Medicare, Reporting and recordkeeping
requirements.
■ For the reasons set forth in the
preamble, the Centers for Medicare &
Medicaid Services amends 42 CFR
chapter IV as set forth below:
PART 424—CONDITIONS FOR
MEDICARE PAYMENT
1. The authority citation for part 424
continues to read as follows:
■
Authority: Secs. 1102 and 1871 of the
Social Security Act (42 U.S.C. 1302 and
1395hh).
Subpart D—To Whom Payment Is
Ordinarily Made
2. Section 424.57 is amended by—
A. Adding in paragraph (a) the
definition of ‘‘direct solicitation’’ in
alphabetical order.
■ B. In paragraph (a) revising the
definition of ‘‘final adverse action’’.
■ C. Revising the introductory text of
paragraph (c).
■ D. Revising paragraphs (c)(1), (c)(7)
through (c)(9), (c)(11), and (e).
■ E. Adding new paragraphs (c)(27)
through (c)(30).
The additions and revisions read as
follows:
■
■
WReier-Aviles on DSKGBLS3C1PROD with RULES
§ 424.57 Special payment rules for items
furnished by DMEPOS suppliers and
issuance of DMEPOS supplier billing
privileges.
(a) * * *
Direct solicitation means direct
contact, which includes, but is not
limited to, telephone, computer, e-mail,
instant messaging or in-person contact,
by a DMEPOS supplier or its agents to
a Medicare beneficiary without his or
her consent for the purpose of marketing
the DMEPOS supplier’s health care
products or services or both.
*
*
*
*
*
Final adverse action means one or
more of the following actions:
(i) A Medicare-imposed revocation of
any Medicare billing privileges.
(ii) Suspension or revocation of a
license to provide health care by any
State licensing authority.
(iii) Revocation for failure to meet
DMEPOS quality standards.
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
(iv) A conviction of a Federal or State
felony offense (as defined in
§ 424.535(a)(3)(i) within the last 10
years preceding enrollment,
revalidation, or re-enrollment.
(v) An exclusion or debarment from
participation in a Federal or State health
care program.
*
*
*
*
*
(c) Application certification
standards. The supplier must meet and
must certify in its application for billing
privileges that it meets and will
continue to meet the following
standards:
(1) Operates its business and
furnishes Medicare-covered items in
compliance with the following
applicable laws:
(i) Federal regulatory requirements
that specify requirements for the
provision of DMEPOS and ensure
accessibility for the disabled.
(ii) State licensure and regulatory
requirements. If a State requires
licensure to furnish certain items or
services, a DMEPOS supplier—
(A) Must be licensed to provide the
item or service;
(B) Must employ the licensed
professional on a full-time or part-time
basis, except for DMEPOS suppliers
who are—
(1) Awarded competitive bid contracts
using subcontractors to meet this
standard; or
(2) Allowed by the State to contract
licensed services as described in
paragraph (c)(1)(ii)(C) of this section.
(C) Must not contract with an
individual or other entity to provide the
licensed services, unless allowed by the
State where the licensed services are
being performed; and
(iii) Local zoning requirements.
*
*
*
*
*
(7) Maintains a physical facility on an
appropriate site. An appropriate site
must meet all of the following:
(i) Must meet the following criteria:
(A) Except for State-licensed orthotic
and prosthetic personnel providing
custom fabricated orthotics or
prosthetics in private practice,
maintains a practice location that is at
least 200 square feet beginning—
(1) September 27, 2010 for a
prospective DMEPOS supplier;
(2) The first day after termination of
an expiring lease for an existing
DMEPOS supplier with a lease that
expires on or after September 27, 2010
and before September 27, 2013; or
(3) September 27, 2013, for an existing
DMEPOS supplier with a lease that
expires on or after September 27, 2013.
(B) Is in a location that is accessible
to the public, Medicare beneficiaries,
PO 00000
Frm 00042
Fmt 4700
Sfmt 4700
CMS, NSC, and its agents. (The location
must not be in a gated community or
other area where access is restricted.)
(C) Is accessible and staffed during
posted hours of operation.
(D) Maintains a permanent visible
sign in plain view and posts hours of
operation. If the supplier’s place of
business is located within a building
complex, the sign must be visible at the
main entrance of the building or the
hours can be posted at the entrance of
the supplier.
(E) Except for business records that
are stored in centralized location as
described in paragraph (c)(7)(ii) of this
section, is in a location that contains
space for storing business records
(including the supplier’s delivery,
maintenance, and beneficiary
communication records).
(F) Is in a location that contains space
for retaining the necessary ordering and
referring documentation specified in
§ 424.516(f).
(ii) May be the centralized location for
all of the business records and the
ordering and referring documentation of
a multisite supplier.
(iii) May be a ‘‘closed door’’ business,
such as a pharmacy or supplier
providing services only to beneficiaries
residing in a nursing home, that
complies with all applicable Federal,
State, and local laws and regulations.
‘‘Closed door’’ businesses must comply
with all the requirements in this
paragraph.
(8) Permits CMS, the NSC, or agents
of CMS or the NSC to conduct on-site
inspections to ascertain supplier
compliance with the requirements of
this section.
(9) Maintains a primary business
telephone that is operating at the
appropriate site listed under the name
of the business locally or toll-free for
beneficiaries.
(i) Cellular phones, beepers, or pagers
must not be used as the primary
business telephone.
(ii) Calls must not be exclusively
forwarded from the primary business
telephone listed under the name of the
business to a cellular phone, beeper, or
pager.
(iii) Answering machines, answering
services, facsimile machines or
combination of these options must not
be used exclusively as the primary
business telephone during posted
operating hours.
*
*
*
*
*
(11) Agree not to make a direct
solicitation (as defined in § 424.57(a)) of
a Medicare beneficiary unless one or
more of the following applies:
(i) The individual has given written
permission to the supplier or the
E:\FR\FM\27AUR1.SGM
27AUR1
WReier-Aviles on DSKGBLS3C1PROD with RULES
Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Rules and Regulations
ordering physician or non-physician
practitioner to contact them concerning
the furnishing of a Medicare-covered
item that is to be rented or purchased.
(ii) The supplier has furnished a
Medicare-covered item to the individual
and the supplier is contacting the
individual to coordinate the delivery of
the item.
(iii) If the contact concerns the
furnishing of a Medicare-covered item
other than a covered item already
furnished to the individual, the supplier
has furnished at least one covered item
to the individual during the 15-month
period preceding the date on which the
supplier makes such contact.
*
*
*
*
*
(27) Must obtain oxygen from a Statelicensed oxygen supplier (applicable
only to those suppliers in States that
require oxygen licensure.)
(28) Is required to maintain ordering
and referring documentation consistent
with the provisions found in
§ 424.516(f)
(29)(i) Except as specified in
paragraph (c)(29)(ii) of this section, is
prohibited from sharing a practice
location with any other Medicare
supplier or provider.
(ii) The prohibition specified in
paragraph (c)(29)(i) of this section is not
applicable at a practice location that
meets one of the following:
(A) Where a physician whose services
are defined in section 1848(j)(3) of the
Act or a nonphysician practitioner, as
described in section 1842(b)(18)(C) of
the Act, furnishes items to his or her
own patient as part of his or her
professional service.
(B) Where a physical or occupational
therapist whose services are defined in
sections 1861(p) and 1861(g) of the Act,
furnishes items to his or her own patient
as part of his or her professional service.
(C) Where a DMEPOS supplier is colocated with and owned by an enrolled
Medicare provider (as described in
§ 489.2(b) of this chapter). The DMEPOS
supplier—
(1) Must operate as a separate unit;
and
(2) Meet all other DMEPOS supplier
standards.
(30)(i) Except as specified in
paragraph (c)(30)(ii) of this section, is
open to the public a minimum of 30
hours per week.
(ii) The provision of paragraph
(c)(30)(i) of this section is not applicable
at a practice location where a—
(A) Physician whose services are
defined in section 1848(j)(3) of the Act
furnishes items to his or her own
patient(s) as part of his or her
professional service;
VerDate Mar<15>2010
14:41 Aug 26, 2010
Jkt 220001
(B) Licensed non-physician
practitioners whose services are defined
in sections 1861(p) and 1861(g) of the
Act furnishes items to his or her own
patient(s) as part of his or her
professional service; or
(C) DMEPOS supplier is working with
custom made orthotics and prosthetics.
*
*
*
*
*
(e) Failure to meet standards—(1)
Revocation. CMS revokes a supplier’s
billing privileges if it is found not to
meet the standards in paragraphs (b)
and (c) of this section. Except as
otherwise provided in this section, the
revocation is effective 30 days after the
entity is sent notice of the revocation, as
specified in § 405.874 of this
subchapter.
(2) Overpayments associated with
final adverse actions. CMS or a CMS
contractor may reopen (in accordance
with § 405.980 of this chapter) all
Medicare claims paid on or after the
date of a final adverse action (as defined
in paragraph (a) of this section) in order
to establish an overpayment
determination.
*
*
*
*
*
Authority: (Catalog of Federal Domestic
Assistance Program No. 93.773, Medicare—
Hospital Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program).
Dated: August 19, 2010.
Donald M. Berwick,
Administrator, Centers for Medicare &
Medicaid Services.
Approved: August 24, 2010.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010–21354 Filed 8–26–10; 8:45 am]
BILLING CODE 4120–01–P
FEDERAL COMMUNICATIONS
COMMISSION
47 CFR Part 73
[DA 10–1521; MB Docket No. 10–22, RM–
11591].
Radio Broadcasting Services;
DeBeque, Colorado
Federal Communications
Commission.
ACTION: Final rule.
AGENCY:
The Audio Division grants a
Petition for Rule Making issued at the
request of Cochise Media Licenses, LLC,
requesting the substitution of Channel
247C3 for vacant Channel 275C3 at
DeBeque to accommodate the hybrid
application, proposing the reallotment
of Channel 274C3, Crawford, Colorado,
to Channel 275C3 at Battlement Mesa,
SUMMARY:
PO 00000
Frm 00043
Fmt 4700
Sfmt 4700
52649
Colorado, as its first local service. A
staff engineering analysis indicates that
Channel 247C3 can be allotted to
DeBeque consistent with the minimum
distance separation requirements of the
Rules with a site restriction 13.8
kilometers (8.5 miles) northeast of the
community. The reference coordinates
are 39–24–45 NL and 108–05–26 WL.
DATES: Effective September 30, 2010.
ADDRESSES: Secretary, Federal
Communications Commission, 445
Twelfth Street, SW., Washington, DC.
20554.
FOR FURTHER INFORMATION CONTACT:
Rolanda F. Smith, Media Bureau, (202)
418–2180.
SUPPLEMENTARY INFORMATION: This is a
summary of the Commission’s Report
and Order, MB Docket No. 10–22,
adopted August 12, 2010, and released
August 16, 2010. The Notice of
Proposed Rule Making proposed the
substitution of Channel 247C3 for
vacant Channel 275C3 at DeBeque,
Colorado. See 75 FR 4036, published
January 26, 2010. The full text of this
Commission decision is available for
inspection and copying during normal
business hours in the Commission’s
Reference Information Center, 445
Twelfth Street, SW., Washington, DC
20554. The complete text of this
decision may also be purchased from
the Commission’s duplicating
contractor, Best Copy and Printing, Inc.,
445 12th Street, SW., Room CY–B402,
Washington, DC, 20554, telephone 1–
800–378–3160 or https://
www.BCPIWEB.com. This document
does not contain proposed information
collection requirements subject to the
Paperwork Reduction Act of 1995,
Public Law 104–13. In addition,
therefore, it does not contain any
proposed information collection burden
‘‘for small business concerns with fewer
than 25 employees,’’ pursuant to the
Small Business Paperwork Relief Act of
2002, Public Law 107–198, see 44 U.S.C.
3506(c)(4). The Commission will send a
copy of this Report and Order in a
report to be sent to Congress and the
Government Accountability Office
pursuant to the Congressional Review
Act, see 5 U.S.C. 801(a)(1)(A).
List of Subjects in 47 CFR Part 73
Radio, Radio broadcasting.
As stated in the preamble, the Federal
Communications Commission amends
47 CFR part 73 as follows:
■
PART 73—RADIO BROADCAST
SERVICES
1. The authority citation for part 73
continues to read as follows:
■
E:\FR\FM\27AUR1.SGM
27AUR1
Agencies
[Federal Register Volume 75, Number 166 (Friday, August 27, 2010)]
[Rules and Regulations]
[Pages 52629-52649]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21354]
[[Page 52629]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Part 424
[CMS-6036-F]
RIN 0938-AO90
Medicare Program; Establishing Additional Medicare Durable
Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS)
Supplier Enrollment Safeguards
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This final rule will clarify, expand, and add to the existing
enrollment requirements that Durable Medical Equipment and Prosthetics,
Orthotics, and Supplies (DMEPOS) suppliers must meet to establish and
maintain billing privileges in the Medicare program.
DATES: These regulations are effective on September 27, 2010.
FOR FURTHER INFORMATION CONTACT: Barry Bromberg, (410) 786-9953 for
general issues, on-site inspections, maintaining ordering and referring
documentation, and hours of operation.
Kimberly McPhillips, (410) 786-5374 for issues related to
compliance with applicable laws, appropriate sites, direct
solicitation, oxygen suppliers, and prohibition on sharing a practice
location.
SUPPLEMENTARY INFORMATION:
I. Background
A. General Overview
Medicare services are furnished by two types of entities,
providers, and suppliers. At Sec. 400.202, the term ``provider'' is
defined as a hospital, a critical access hospital (CAH), a skilled
nursing facility (SNF), a comprehensive outpatient rehabilitation
facility (CORF), a home health agency (HHA), or a hospice that has in
effect an agreement to participate in Medicare, or a clinic, a
rehabilitation agency, or a public health agency that has in effect a
similar agreement but only to furnish outpatient physical therapy or
speech pathology services, or a community mental health center that has
in effect a similar agreement but only to furnish partial
hospitalization services. The term ``provider'' is also defined in
sections 1861(u) and 1866(e) of the Social Security Act (the Act).
For purposes of the DMEPOS supplier standards, the term
``supplier'' is defined in Sec. 424.57(a) as an entity or individual,
including a physician or Part A provider, that sells or rents Part B
covered DMEPOS items to Medicare beneficiaries that meet the DMEPOS
supplier standards. This final rule applies to all DMEPOS suppliers and
amends the DMEPOS supplier standards set forth at Sec. 424.57(c).
Those individuals or entities that do not furnish DMEPOS items but
furnish other types of health care services only (for example,
physician services or nurse practitioner services) would not be subject
to this requirement. A supplier that furnishes durable medical
equipment, prosthetics, orthotics, and suppliers (DMEPOS) is one
category of supplier. Other supplier categories may include, for
example, physicians, nurse practitioners, and physical therapists. If a
supplier, such as a physician or physical therapist, also provides
DMEPOS to a patient, then the supplier is also considered to be a
DMEPOS supplier. The term ``DMEPOS'' encompasses the types of items
included in the definition of medical equipment and supplies in section
1834(j)(5) of the Act.
In FY 2007, the Medicare program spent more than $10 billion for
DMEPOS supplies, and in March 2008, there were 113,154 individual
DMEPOS suppliers. However, due to the affiliation of some DMEPOS
suppliers with chains, there were 65,984 unique billing numbers. The
largest concentrations of DMEPOS suppliers were located in five States:
California (approximately 9 percent), Texas (approximately 7 percent),
Florida (approximately 7 percent), New York (approximately 6 percent)
and Pennsylvania (approximately 5 percent). We believe that
approximately 20 percent of the DMEPOS suppliers are located in rural
areas throughout the United States and that the vast majority of DMEPOS
suppliers are small entities (based on Medicare reimbursement alone).
The term ``durable medical equipment'' is defined at section
1861(n) of the Act. This definition, in part, excludes from coverage as
DMEPOS, items furnished in SNFs and hospitals. Also, the term DMEPOS is
included in the definition of ``medical and other health services'' in
section 1861(s)(6) of the Act. Furthermore, the term is defined in
Sec. 414.202 as equipment furnished by a supplier or a HHA that--
Can withstand repeated use;
Is primarily and customarily used to serve a medical
purpose;
Generally is not useful to an individual in the absence of
an illness or injury; and
Is for use in the home.
Examples of DMEPOS supplies include items such as blood glucose
monitors, hospital beds, nebulizers, oxygen delivery systems, and
wheelchairs.
Prosthetic devices are included in the definition of ``medical and
other health services'' under section 1861(s)(8) of the Act. Prosthetic
devices are defined in this section of the Act as ``devices (other than
dental) which replace all or part of an internal body organ (including
colostomy bags and supplies directly related to colostomy care),
including replacement of such devices, and including one pair of
conventional eyeglasses or contact lenses furnished subsequent to each
cataract surgery with insertion of an intraocular lens.'' Other
examples of prosthetic devices include cardiac pacemakers, cochlear
implants, electrical continence aids, electrical nerve stimulators, and
tracheostomy speaking valves.
Section 1861(s)(9) of the Act provides for the coverage of ``leg,
arm, back, and neck braces, and artificial legs, arms, and eyes,
including replacement of required because of a change in the patient's
physical condition.'' As indicated by section 1834(h)(4)(C) of the Act,
these items are often referred to as ``orthotics and prosthetics.''
Under section 1834(h)(4)(B) of the Act, prosthetic devices do not
include parenteral and enteral nutrition nutrients and implantable
items payable under section 1833(t) of the Act.''
Section 1861(s)(5) of the Act includes ``surgical dressings,
splints, casts, and other devices used for reduction of fractures and
dislocation'' as one of the ``medical and other health services'' that
is covered by Medicare. Other items that may be furnished by suppliers
would include (among others):
Prescription drugs used in immunosuppressive therapy
furnished to an individual who receives an organ transplant for which
payment is made under this title, and that are furnished within a
certain time period after the date of the transplant procedure as noted
at section 1861(s)(2)(j) of the Act.
Extra-depth shoes with inserts or custom molded shoes with
inserts for an individual with diabetes as listed at section
1861(s)(12) of the Act.
Home dialysis supplies and equipment, self-care home
dialysis support services, and institutional dialysis services and
supplies included at section 1861(s)(2)(F) of the Act.
Oral drugs prescribed for use as an anticancer therapeutic
agent as specified in section 1861(s)(2)(Q) of the Act.
Self-administered erythropoietin as described in section
1861(s)(2)(O) of the Act.
[[Page 52630]]
The National Supplier Clearinghouse (NSC) is the Center for
Medicare & Medicaid Services' (CMS) designated national enrollment
contractor for DMEPOS suppliers. The primary functions of the NSC are
to: (1) Ensure that only qualified suppliers of DMEPOS are enrolled or
remain enrolled in the Medicare program; (2) process enrollment
application in timely and accurate manner; and (3) take the necessary
actions to revoke enrolled suppliers who no longer meet supplier
standards.
B. Statutory Authority
Various sections of the Act and the regulations require providers
and suppliers to furnish information concerning the amounts due and the
identification of individuals or entities that furnish medical services
to beneficiaries before payment can be made. The following is an
overview of the sections that grant this authority:
Sections 1102 and 1871 of the Act provide general
authority for the Secretary of Health and Human Services (the
Secretary) to prescribe regulations for the efficient administration of
the Medicare program. Under this authority, this final rule will
require the collection of information from providers and suppliers for
the purpose of enrolling in the Medicare program and granting
privileges to bill the program for health care services furnished to
Medicare beneficiaries.
Sections 1814(a), 1815(a), and 1833(e) of the Act require
the submission of information necessary to determine the amounts due a
provider or other person.
Section 1834(j)(1)(A) of the Act states that no payment
may be made for items furnished by a supplier of medical equipment and
supplies unless such supplier obtains (and renews at such intervals as
the Secretary may require) a supplier number. In order to obtain a
supplier billing number, a supplier must comply with certain supplier
standards as identified by the Secretary.
Section 1842(r) of the Act requires CMS to establish a
system for furnishing a unique identifier for each physician who
furnishes services for which payment may be made. To complete this, we
need to collect information unique to that physician.
Section 1862(e)(1) of the Act states that no payment may
be made when an item or service was at the medical direction of an
individual or entity that is excluded in accordance with sections 1128,
1128A, 1156, or 1842(j)(2) of the Act.
Section 4312 of the Balanced Budget Act of 1997 (BBA)
(Pub. L. 105-33) amended section 1834 of the Act to require that
certain Medicare supplies of durable medical equipment, prosthetics,
and supplies (DMEPOS) to furnish CMS with a surety bond in an amount
not less than $50,000.
Section 4313 of the BBA amended sections 1124(a)(1) and
1124A of the Act to require disclosure of both the Employer
Identification Number (EIN) and Social Security Number (SSN) of each
provider or supplier, each person with ownership or control interest in
the provider or supplier, any subcontractor in which the provider or
supplier directly or indirectly has a 5 percent or more ownership
interest, and any managing employees including Directors and Board
Members of corporations and non-profit organizations and charities. The
``Report to Congress on Steps Taken to Assure Confidentiality of Social
Security Account Numbers as Required by the Balanced Budget Act'' was
signed by the Secretary and sent to the Congress on January 26, 1999.
This report outlines the provisions of a mandatory collection of SSNs
and EINs effective on or after April 26, 1999.
Section 31001(i)(1) of the Debt Collection Improvement Act
of 1996 (DCIA) (Pub. L. 104-134) amended section 7701 of 31 U.S.C. by
adding paragraph (c) to require that any person or entity doing
business with the Federal Government must provide their Tax
Identification Number (TIN).
Section 936(a) of the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108-173)
amended section 1866 of the Act by adding a new subsection (j)(1) to
require the Secretary to establish a process for the enrollment of
providers of services and suppliers.
Section 302(a)(1) of MMA amended the Act to require the
Secretary to develop quality standards for DMEPOS suppliers.
Section 154(b) of the MIPPA amended the Act to establish a
deadline for DMEPOS accreditation.
Section 6405(a) of the Affordable Care Act (ACA) requires that in
order for payment for services to be made, a physician who orders DME
for individuals must be a Medicare participating physician enrolled
under section 1866(j) of the Act or an eligible professional under
section 1848(k)(3)(B) of the Act that is enrolled under section 1866(j)
of the Act.
We are authorized to collect information on the Medicare enrollment
application (that is, the CMS-855, (Office of Management and Budget
(OMB) approval number 0938-0685)) to ensure that correct payments are
made to providers and suppliers under the Medicare program as
established by Title XVIII of the Act.
II. Provisions of the Proposed Rule
In the January 25, 2008 Federal Register (73 FR 4503), we published
a proposed rule that clarified, revised, and added to the DMEPOS
supplier standards in Sec. 424.57.
In Sec. 424.57(c)(1), we proposed to revise this supplier standard
by adding language to clarify that a DMEPOS supplier must be licensed
to provide licensed service(s) and cannot contract with an individual
or entity to provide the licensed service(s).
The purpose of this standard is to ensure that DMEPOS suppliers
obtain and maintain the necessary State licenses required to furnish
the services provided to Medicare beneficiaries. In addition, we
believe that each DMEPOS supplier is responsible for determining what
licenses are required to operate a DMEPOS supplier's business. While
the NSC maintains information regarding State licensure laws, we do not
believe that the NSC is responsible for notifying any supplier of what
licenses are required or that any changes have occurred in the State
licensing requirements. We believe that we are enrolling DMEPOS
suppliers, not third party agents that subcontract their operations to
suppliers that are not enrolled or cannot enroll in the Medicare
program. Therefore, to ensure that only qualified suppliers are
enrolled or maintain enrollment in the Medicare program, we maintain
that a DMEPOS supplier must be licensed to provide licensed service(s)
and cannot contract with an individual or entity to provide the
licensed service(s).
In Sec. 424.57(c)(7), we proposed to clarify the supplier standard
for maintaining a physical facility on an appropriate site. Specially,
we proposed to clarify the term, ``appropriate site.'' In addition, we
stated that an ``appropriate site'' applies to ``closed door''
businesses, (such as pharmacies/suppliers providing services only to
beneficiaries residing in a nursing home). We also solicited comments
on whether we should establish a minimum square footage requirement to
the definition of an appropriate site and what, if any, appropriate
exceptions would apply to a minimum square footage requirement.
The supplier location must be accessible during posted business
hours to beneficiaries and to CMS, and must maintain a visible sign and
posted hours of operation. We believe that all DMEPOS suppliers must
have a permanent, durable sign that is visible at the main entrance of
the facility and
[[Page 52631]]
positioned so that it is visible to the public, including customers
using wheelchairs.
In Sec. 424.57(c)(8), we proposed to clarify this provision by
revising (c)(8) to read as follows: ``Permits CMS, the NSC, or agents
of CMS or the NSC to conduct on-site inspections to ascertain supplier
compliance with the requirements of this section.'' If the NSC or its
agents are unable to perform a site visit during a supplier's posted
business hours, the NSC would deny billing privileges for prospective
applicants or would revoke the billing privileges of DMEPOS suppliers
enrolled in the Medicare program.
In Sec. 424.57(c)(9), we proposed to revise this supplier standard
to exclude the use of cell phones and beepers/pagers as a method of
receiving calls or using ``call forwarding'' to forward a call to a
cell phone or beeper/pager from the public or beneficiaries during the
supplier's posted hours of operation. We maintain that DMEPOS suppliers
who are utilizing cell phones, call forwarding, beeper numbers, pagers,
answering services or other methods to receive telephone calls in a
location other than the place of business for business calls during
their posted hours of operations are not in compliance with this
standard and that DMEPOS suppliers who exclusively use answering
machines or answering services during their posted hours of operations
are not in compliance with this standard. Therefore, we revised this
standard to read, ``Maintains a primary business telephone that is
operating at the appropriate site listed under the name of the business
locally or toll-free for beneficiaries. The use of cellular phones,
beeper numbers, and pagers as the primary business phone is prohibited.
Additionally, DMEPOS suppliers are prohibited from forwarding calls
from the primary business telephone listed under the name of the
business to a cellular phone, or a beeper/pager. The exclusive use of
answering machines, answering services or facsimile machine (or
combination of these options) cannot be used as the primary business
telephone during posted operating hours.''
In Sec. 424.57(c)(10), we proposed to revise this provision to
specify that the DMEPOS supplier has a comprehensive liability
insurance policy in the amount of at least $300,000 per incident that
covers both the supplier's place of business and all customers and
employees of the supplier and ensures that insurance policy must remain
in force at all times. In addition, we proposed that a DMEPOS supplier
must list the NSC as a certificate holder on the policy and notify the
NSC in writing within 30 days of any policy changes or cancellations.
In Sec. 424.57(c)(11), we proposed to revise this supplier
standard to clarify that suppliers cannot directly solicit patients,
which includes, but is not limited to, a prohibition on telephone,
computer e-mail or instant messaging, coercive response Internet
advertising on sites unrelated to DMEPOS products, or in-person
contacts. We also proposed that DMEPOS supplier may only contact the
Medicare beneficiary under the current provisions at Sec.
424.57(c)(11)(i) through (iii). We believe that if CMS or the NSC
through on-site inspection obtains or develops evidence that a DMEPOS
supplier has made prohibited contacts with Medicare beneficiaries in
violation of the provisions found in this section that CMS or the NSC
may revoke that supplier's billing privileges, and may determine if
such billing may be for fraudulent or unnecessary supplies.
In Sec. 424.57(c)(12), we proposed to revise the provision to
clarify its intent. Specifically, we proposed that a DMEPOS supplier:
(1) Is responsible for maintaining proof of the delivery in the
beneficiary's file; (2) must furnish information to beneficiaries at
the time of delivery of items as to how the beneficiary can contact the
supplier by telephone; (3) must provide the beneficiary with
instructions on how to safely and effectively use the equipment or
contract this service to a qualified individual; (4) is responsible for
providing instruction on the safe and effective use of the equipment
that should be completed at the time of delivery; and (5) must document
that this instruction has taken place. Our proposal was based on the
belief that a DMEPOS supplier is solely responsible for delivery of
Medicare-covered items and for instruction on the use of those items.
While we believe that a DMEPOS supplier may choose to contract out the
delivery of Medicare-covered items to another individual or entity, the
DMEPOS supplier has ultimate responsibility for ensuring delivery in
accordance with this standard and for maintaining all necessary
documentation to demonstrate that the beneficiary received the
Medicare-covered item and appropriate instructions for its use. We
believe that our revised interpretation of this section will help to
ensure that instructions for the safe and appropriate use of products
will be given to beneficiaries.
In Sec. 424.57(c)(27), we proposed a new standard that specified
that the DMEPOS supplier must obtain oxygen from a State-licensed
oxygen supplier. To ensure that DMEPOS suppliers meet and maintain this
standard, we believe that DMEPOS suppliers who are supplying oxygen
must contract with a supplier licensed by the State to provide them
with oxygen. Obviously, this standard does not apply when the State
does not license oxygen suppliers. We understand that in certain areas,
DMEPOS suppliers may obtain oxygen from oxygen suppliers in other
States. However, when a DMEPOS supplier is located in a State where
licensure is required, then they must obtain their oxygen from a State-
licensed oxygen supplier, regardless of which State the oxygen supplier
obtained their licensure. We believe that this standard would help to
protect Medicare beneficiaries and promote quality in the furnishing of
oxygen.
In Sec. 424.57(c)(28), we proposed a new supplier standard that
states that the supplier is required to maintain ordering and referring
documentation, including the National Provider Identifier, received
from a physician, nurse practitioner, physician assistant, clinical
social worker, or certified nurse midwife, for 7 years after the claim
has been paid. We maintain that a DMEPOS supplier should retain the
necessary ordering and referring documentation received from
physicians, nurse practitioners, physician assistants, clinical social
workers, or certified nurse midwives to assure themselves that coverage
criterion for an item has been met. If the information in the patient's
medical record does not adequately support the medical necessity for
the item, the supplier is liable for the dollar amount involved unless
a properly executed Advance Beneficiary Notice of possible denial has
been obtained.
In Sec. 424.57(c)(29), we proposed a new standard that specifies
that the supplier is prohibited from sharing a practice location with
another Medicare supplier. In addition, we solicited comments on
whether we should establish an exception to this space sharing proposal
for physicians and nonphysician practitioners and the circumstances
which warrant an exception since we are aware that physicians and other
licensed nonphysician practitioners may obtain their own DMEPOS
supplier number and furnish DMEPOS from their office. We believe that
allowing a DMEPOS supplier to commingle its practice location with
another DMEPOS supplier effectively limits the ability of CMS and the
NSC to ensure that each DMEPOS supplier meets all of the supplier
standards specified at Sec. 424.57. Since we are aware that physicians
and other licensed nonphysician practitioners
[[Page 52632]]
may obtain their own DMEPOS supplier number and furnish DMEPOS from
their office, we solicited comments on whether we should establish an
exception to this space sharing proposal for physicians and
nonphysician practitioners and the circumstances which warrant an
exception.
In Sec. 424.57(c)(30), we proposed a new supplier standard that
would require a DMEPOS supplier to be open to the public a minimum of
30 hours per week, except for those DMEPOS suppliers who are working
with custom-made or fitted orthotics and prosthetics. We believe that
most legitimate DMEPOS suppliers are open to the public for more than
40 hours per week and that all legitimate DMEPOS would need to be open
a minimum of at least 30 hours per week in order to attract, retain,
and serve Medicare beneficiaries. Given that Medicare beneficiaries may
not be able to find transportation during limited operating hours, the
DMEPOS supplier must be open and available for periods long enough for
beneficiaries to readily access their facility. We believe that most
legitimate DMEPOS suppliers are open to the public for more than 40
hours per week and that all legitimate DMEPOS would need to be open a
minimum of at least 30 hours per week in order to attract, retain, and
serve Medicare beneficiaries. To ensure that DMEPOS suppliers are able
to report any change in their posted business hours, we are proposing
to revise the CMS-855S Medicare enrollment application to accommodate
this proposed change.
In Sec. 424.57(c)(31), we proposed to add a new supplier standard
that specified that a DMEPOS supplier could not have Internal Revenue
Service (IRS) or a State taxing authority tax delinquency. We also
proposed to define a ``tax delinquency'' as meaning an amount of money
owed to the United States or a State: a conviction or civil judgment
for tax evasion, a criminal or civil charge of tax evasion, or the
filing of a tax lien.
In Sec. 424.57(d), we proposed to redesignate the current text as
paragraph (d)(1) and proposed adding a new paragraph that specified
that ``CMS, the NSC, or CMS designated contractor establishes a
Medicare overpayment from the date of an adverse legal action or felony
conviction (including felony convictions within the 10 years preceding
enrollment or revalidation of enrollment) that precludes payment. In
addition, we proposed that any overpayment assessed by CMS or its
designated contractor due to a lack of reporting would follow the
existing rules governing Medicare overpayments set forth at Sec.
405.350 et seq. We believe that Sec. 424.57(d)(2) is necessary because
some DMEPOS suppliers fail to report adverse legal actions and felony
convictions to the NSC within the 30 days of the reportable event.
Since it is essential that DMEPOS suppliers notify the NSC of all
adverse legal actions and felony convictions within 30 days of the
reportable event, we believe that it is essential to establish this new
provision. This new provision would allow the CMS, the NSC, or a
designated Medicare contractor the authority to assess and collect an
overpayment from the time of the reportable event. In addition, the
CMS, the NSC, or a designated CMS contractor would revoke the DMEPOS
supplier's Medicare billing privileges, in accordance with Sec.
424.57(d)(1), if the legal adverse action or felony conviction
precludes participation in or payment from the Medicare program.
III. Analysis of and Responses to Public Comments
In the January 25, 2008 Federal Register (73 FR 4503), we published
a proposed rule that clarified, revised, and added to the DMEPOS
supplier standards in Sec. 424.57.
We received 208 timely comments in response to the proposed rule.
In this section of the final rule we present a summary of our proposals
and address the comments received on these proposals.
A. Clarifications and Revisions of Existing DMEPOS Supplier Standards
1. Licensure Requirements
In Sec. 424.57(c)(1), we proposed to revise this supplier standard
by adding language to clarify that a DMEPOS supplier must be licensed
to provide licensed service(s) and cannot contract with an individual
or entity to provide the licensed service(s). These licensed services
include but are not limited to supplying oxygen or a general DMEPOS
license.
Comment: A commenter believes the NSC should maintain and make
available, a list of each State's licensing requirements.
Response: The National Supplier Clearinghouse (NSC) does maintain
information regarding State licensure laws for DMEPOS suppliers on its
Web site (see https://www.palmettogba.com/nsc). However, the DMEPOS
supplier is ultimately responsible for determining what business,
product and other applicable licenses are required for his or her
business, regardless of the accuracy of the information provided on the
NSC Web site. We also believe it is the business owner's responsibility
to be aware of any changes in the State licensing requirements for his
or her business. During the enrollment and reenrollment process the NSC
verifies that the DMEPOS supplier is in compliance with all applicable
State licensing requirements.
Comment: Several commenters supported requiring DMEPOS suppliers to
be licensed for all services they provide and that DMEPOS suppliers
should not be allowed to contract out for these services. In addition,
one commenter stated that the changes proposed to the licensure
requirement for Medicare suppliers are necessary and beneficial.
Response: We agree and are revising Sec. 424.57(c)(1)(ii)(C) to
address the commenters' concern regarding contracting out of services.
In addition, this requirement applies to the competitive bidding
program as governed by part 414, subpart F.
Comment: A commenter believes that because of the complexity of
State licensing requirements, it is too severe to revoke all billing
numbers when licensing requirements are not met in only one State.
Response: We do not believe that there are any exceptions to State
licensing requirements, unless the State in which the DMEPOS supplier
furnishes services provides for such an exception, and that exception
does not conflict with Federal law. Moreover, while a DMEPOS supplier
can enroll using a single tax identification number (TIN) for one or
more practice locations, a DMEPOS supplier also may obtain different
TINs for each practice location. If the DMEPOS supplier makes the
business decision to enroll multiple practice locations under the same
TIN, a revocation by the NSC of this TIN will necessitate the
revocation of related businesses associated with that TIN.
Comment: One commenter stated that restricting licensed
professionals to W-2 employees likely will increase overall operating
expenses and requested that we clarify that licensed professionals may
be hired as either part-time or full-time employees.
Response: We agree and have revised Sec. 424.57(c)(1)(ii) to
clarify that the licensed professionals must be part-time or full-time
employees.
Comment: A commenter stated that Sec. 424.57(c)(1)(ii) as written,
would allow DMEPOS suppliers to contract with nonlicensed individuals
to avoid contracting with licensed individuals. In addition, it would
not be financially feasible for all DMEPOS suppliers to have licensed
professionals on staff, and therefore, CMS should allow contracting for
services as long as they are in compliance with State requirements.
[[Page 52633]]
Response: We do not believe that this provision is written in such
a way as to allow DMEPOS suppliers to contract with nonlicensed
individuals to avoid employing part-time or full-time W-2 employees. In
addition, we believe that a DMEPOS supplier who does not have a
licensed individual on staff (part-time or full-time) as a W-2 employee
would be in violation of Sec. 424.57(c)(1). Moreover, while we are
concerned with the financial burden placed on small businesses, we
recognize that a certain amount of capital is required to establish and
maintain a business. To this end, we believe that enrolled DMEPOS
suppliers should be required to meet State licensing qualifications,
rather than subcontracting to a third-party agent who may or may not be
qualified. Moreover, since we cannot ensure with any degree of
certainty, the qualifications of a subcontracted individual or his or
her compliance with Federal, State, and local licensure requirements,
we believe the Medicare program and its Medicare beneficiaries would be
better served if we could verify that a DMEPOS supplier meets the
applicable State licensing requirements for a DMEPOS supplier's chosen
specialty.
Comment: One commenter questioned whether CMS considers a co-
employment arrangement with a Professional Employment Organization to
be compliant or noncompliant with this proposed rule.
Response: We would consider a co-employment arrangement with a
professional employment organization to be compliant with this proposed
rule provided any licensed services are performed by an individual who
receives a W-2 with the DMEPOS supplier's legal business name on it.
For situations of co-employment, the W-2 also may have the legal
business name of the professional employment organization, but this
must be in addition to the DMEPOS supplier's legal business name.
Comment: A commenter requested that physical therapy clinics be
exempt from the requirement for State certification that applies to
DMEPOS suppliers because it will affect patient access to necessary
care if the physical therapy clinic in which an individual was being
treated was not certified as a DMEPOS supplier and that it is an
unnecessary burden to apply the same rules to licensed health care
professionals as supplier companies.
Response: We believe that enrolled DMEPOS suppliers should meet all
applicable State licensing requirements. We do not believe it is an
unnecessary burden to apply the same rules to licensed health care
professionals as supplier companies; in fact, to do otherwise would
allow different regulatory and compliance standards to emerge. Finally,
many of the rules of licensed health care professionals and many of the
rules of the supplier companies are not duplicative or consecutive;
rather, they are cumulative.
Comment: Several commenters believe that the licensing requirement
provision is too restrictive and should be revised to state that
properly licensed personnel are available to furnish the offered
services. In addition, these commenters stated that the current
language is too broad and would include administrative staff.
Response: This final regulation states that a DMEPOS supplier must
be in compliance with Federal, State, and local laws and requirements.
It also states a DMEPOS supplier cannot contract with an individual or
other entity to provide licensed services. This requirement only would
apply to a DMEPOS supplier's administrative staff if the administrative
staff member is also responsible for providing a licensed service for
the DMEPOS supplier. Moreover, we are promoting a State's prerogatives
on licensure by imposing this requirement only in States where there
are no such rules for contracting for licensed services. Rather, we are
hoping to diminish the chance of fraudulent practices by requiring that
a DMEPOS supplier directly furnish licensed services.
Comment: One commenter believes disallowing contracting with
individuals or entities is unfair to the small supplier.
Response: While we are concerned with the potential financial
burden that this change imposes on small businesses, and we will
monitor the impact of this requirement on small businesses. We believe
that small DMEPOS suppliers should meet the applicable State licensing
requirements for the services they provide.
Comment: One commenter recommended that rather than restricting the
practice of contracting with licensed personnel, CMS should require the
supplier to purchase additional insurance to cover the licensed person.
Response: We believe that a DMEPOS supplier must meet the
applicable State licensing requirements for the services they provide
to Medicare beneficiaries. In addition, while we agree that additional
insurance may provide additional protection for the supplier, it does
not help to ensure that a Medicare beneficiary is receiving quality
products and instruction from a licensed individual and we will allow
contracting for licensed services only when the State where the item or
service is supplied permits a DMEPOS supplier to contract for licensed
services. Moreover, we believe that DMEPOS suppliers participating in
competitive bidding must maintain all applicable State licenses for the
products and services they are bidding on or furnishing in each
competitive bidding area. In addition, we believe that it is the
responsibility of DMEPOS suppliers participating in competitive bidding
to ensure that any subcontractor obtains and maintains all appropriate
State licenses in the area where they are providing services. We
maintain that DMEPOS suppliers awarded a competitive bidding contract
and that are subcontracting will be allowed on a phase-in basis for
licenses services and licensed professionals participating in
competitive bidding.
Comment: One commenter believes that this regulation is in conflict
with some State licensing requirements, as some States permit DMEPOS
suppliers to comply with its State licensing requirements by
contracting with an individual or other entity to provide the licensed
service. In addition, the commenter states a Federal regulation cannot
supersede the historic police powers of the State unless it was the
clear and manifest purpose of the Congress (see Downhaur v. Somani).
Response: We agree with this commenter because, State licensing
laws and regulations on the licensure of DMEPOS suppliers govern how
DMEPOS suppliers furnish items within a particular State. Therefore, we
maintain that a DMEPOS supplier can contract for licensed services only
when the State where the licensed service is being provided allows for
this sort of arrangement consistent with Sec. 424.57(c)(1)(ii)(C).
Comment: A commenter does not believe that CMS should be in the
business of professional licensing.
Response: It is important to note that we require the DMEPOS
supplier to be State licensed, not to obtain a license from CMS. This
change will help to ensure that DMEPOS suppliers are meeting State
licensing requirements.
Comment: Several commenters recommended that the provision of not
contracting out licensed services and the W-2 employee provisions of
this standard only apply when not addressed by State licensing
requirements.
Response: We agree with these commenters. We believe that DMEPOS
suppliers must meet all applicable State licensing requirements and
that this
[[Page 52634]]
standard will only apply when not addressed by State licensing
requirements.
Comment: Several commenters do not believe it should matter if the
service is furnished by a W-2 employee or a 1099 contractor so long as
both are properly licensed with no adverse legal action current or
pending.
Response: We agree with these commenters because a DMEPOS supplier
is accountable for meeting the applicable State licensing requirements,
and by requiring that W-2 employees or a 1099 contractor (when allowed
by State law) of the supplier are appropriately licensed, the NSC can
verify that a DMEPOS supplier is meeting all applicable State licensing
requirements.
Comment: One commenter stated that they are opposed to the
revisions in Sec. 424.57(c)(1) because it would prevent all but the
largest DMEPOS suppliers from bidding on contracts under the DMEPOS
competitive bidding program because smaller businesses would not be
able to hire staff all the potential licensed professionals as W-2
employees.
Response: We want to clarify that the employment requirement will
not apply to contract suppliers participating in the competitive
bidding program and we have reflected this intention in Sec.
424.57(c)(1)(ii)(B).
Comment: Several commenters believe that the proposed rule
conflicts with the rules for participation in the competitive bidding
program, as the competitive bidding program itself allows items and
services in a product category to be supplied directly or through a
subcontractor and provides safeguards to allow subcontracting.
Response: We agree with these commenters, and have revised Sec.
424.57(c)(1)(ii)(B) to reflect that the employment requirement for the
furnishing of licensed services does not apply to contract suppliers
participating in the competitive bidding program.
Comment: One commenter stated that this regulation conflicts with
CMS' accreditation standards which permit contracting for licensed
services, so long as the DMEPOS supplier complies with State licensure
laws and is ultimately responsible for the services provided by a
contractor.
Response: We have amended Sec. 424.57(c)(1) to permit contracting
for licensed services, so long as the State where the licensed services
are being performed allow for such contracting and the DMEPOS supplier
complies with State licensure laws and is ultimately responsible for
the services provided by a contractor. The supplier standards in Sec.
424.57 are separate from the quality standards which are used by
accrediting organizations. This regulation does not conflict with our
accreditation standards listed at Sec. 424.57(c)(22) through (c)(25).
Comment: A commenter stated that the proposed rule is unnecessary
because many of the DMEPOS suppliers must be accredited by September
30, 2009 on top of already having to meet the State licensure
requirements. Moreover, supplier's ability to use subcontractors for
the purpose of assuring service throughout a competitive bidding area
would be limited which could disadvantage the small suppliers compared
to large suppliers.
Response: We disagree with these commenters because a DMEPOS
supplier is accountable for meeting the applicable State licensing
requirements, and by requiring DMEPOS suppliers to employ individuals
who are appropriated licensed, the NSC can verify that a DMEPOS
supplier is meeting all applicable State licensing requirements.
Comment: Several commenters stated that the standard to prohibit a
DMEPOS supplier from contracting with an individual or other entity to
provide the licensed service places an unfair burden on small suppliers
who at times must contract with licensed personnel or provide specific
services to the supplier's patients. Also, this requirement makes it
seem like CMS is singling out DMEPOS suppliers by not allowing them the
use of staffing agencies when demand is great. In addition, the
commenter believes that this standard would restrict suppliers that
have full time respiratory therapists from hiring temporary licensed
respiratory therapists during times of vacation, illness or increased
staffing needs, and have a detrimental effect on patient's access to
care and restrict respiratory therapists from performing duties in the
patient's home.
Response: We believe that a DMEPOS supplier must be licensed to
provide licensed services, and therefore, we are not adopting any
exceptions to this provision except where a State permits contracting
for licensed services. In addition, many small businesses currently
have an owner or W-2 employee who is licensed to provide a service that
requires a State licensure. We believe that the changes we are adopting
in this final regulation will not have a detrimental effect on
patient's access to care and do not restrict respiratory therapists
from performing duties in the patient's home. Finally, as stated
previously, we are clarifying that DMEPOS supplier may hire a licensed
W-2 employee on a part-time or full-time basis and we will permit
contracting for licensed services, so long as the State permits
contracting for licensed services and the DMEPOS supplier complies with
State licensure laws and is ultimately responsible for the services
provided by a contractor.
Comment: One commenter asks how disallowing the contracting of
licensed individuals could affect competitive bidding, given that a
supplier is required to submit a bid for all of the oxygen modalities.
Response: When allowed under State law, we will permit contracting
for licensed services, so long as the DMEPOS supplier complies with
State licensure laws and is ultimately responsible for the services
provided by a contractor. In order for a DMEPOS supplier to be able to
participate in the DMEPOS competitive bidding program, the supplier
must comply with all of the DMEPOS supplier standards and be enrolled
in the Medicare program as a DMEPOS supplier.
Comment: One commenter asked if this rule is requiring all oxygen
suppliers to directly provide liquid oxygen since CMS competitive
bidding rules allow for contracting in certain areas.
Response: No, all oxygen suppliers do not need to directly provide
liquid oxygen. A supplier can use a qualified subcontractor to deliver
oxygen. If the supplier is not in a competitive bidding area and does
not furnish liquid oxygen as part of their business model and the
prescription specifically indicates that the physician is ordering
liquid oxygen, the supplier would either need to get approval from the
ordering physician to furnish a different modality or refer the
beneficiary to another supplier. If a physician orders liquid oxygen in
areas that fall under competitive bidding, then the oxygen supplier
must supply liquid oxygen.
Comment: A commenter stated that the proposed rule would result in
different Federal requirements for hospital-based DMEPOS suppliers
based solely on the location of the supplier and further disadvantage
hospitals because hospitals generally use independent contractors to
perform its services.
Response: We disagree with this commenter because all DMEPOS
suppliers, including those based at hospitals or operated by other
providers, are required to meet State licensing requirement for the
services they provide. This change will enable CMS or our designated
contractor to verify that the supplier is meeting the
[[Page 52635]]
applicable State licensing requirements for the services that it
furnishes.
2. Physical Facility--Appropriate Site
In Sec. 424.57(c)(7), we proposed to clarify the supplier standard
for maintaining a physical facility on an appropriate site. Specially,
we proposed to clarify the term, ``appropriate site.'' In addition, we
stated that an ``appropriate site'' applies to ``closed door''
businesses (such as pharmacies/suppliers providing services only to
beneficiaries residing in a nursing home). We also solicited comments
on whether we should establish a minimum square footage requirement to
the definition of an appropriate site and what, if any, appropriate
exceptions would apply to a minimum square footage requirement.
Comment: One commenter recommended that a minimum square footage
requirement be established so the suppliers cannot qualify for
participation in the Medicare program with unsuitable locations. This
commenter stated that square footage should be adequate to store the
necessary inventory.
Response: We appreciate this comment and have adopted a minimum
square footage requirement of 200 square feet in Sec. 424.57(c)(7). We
agree with this commenter that a DMEPOS supplier must maintain a
minimum area of space for inventory, storage, and including patient
records.
Comment: Several commenters stated that the variability between
suppliers and services provided are too great to set a minimum number
of square feet required to attain a supplier number.
Response: We appreciate these comments and considered them in
establishing minimum square footage requirements within Sec.
424.57(c)(7).
Comment: A number of commenters opposed the establishment of a
specific square footage requirement for supplier' physical locations.
Response: Since many DMEPOS suppliers who do not have a minimum
square footage have been determined in the past to be fraudulent
suppliers or have provided less than sufficient services to Medicare
beneficiaries, we believe that a minimum square footage requirement is
necessary to ensure that DMEPOS suppliers are operating a legitimate
business. However, based on public comments, we were concerned that
establishing a minimum square footage requirement of 500 square feet
may impose an undue burden for some suppliers. Accordingly, based on
public comments and our review of existing supplier operations, we are
adopting a minimum square footage of 200 square feet per practice
location. We believe that 200 square feet represents the smallest
practice location that can be used to meet the supplier standards in
Sec. 424.57. Specifically, we would expect that most practice
locations have space for inventory, storage, including patient records,
a desk and chairs, and in most cases a restroom for employees and
customers.
Comment: One commenter recommended that we clarify that DMEPOS
suppliers may continue to utilize centralized business centers to house
beneficiary and other business records and centralized customer call
centers are permissible under this revised standard.
Response: We believe that it is necessary to have prompt access to
delivery, maintenance, and beneficiary records at the supplier's
facility where the beneficiary receives services. This enables the
beneficiary to promptly obtain necessary information and for CMS and
our agents to perform a review of the records. We agree that the use of
a centralized business center by a multisite supplier to house these
records when the information in the records can be furnished to the
beneficiary or CMS and our agents, or both. For example, the supplier
location could use a computer terminal to access the records which are
being stored off site. Then, it could express mail the documents
requested.
Comment: A commenter stated that it is not economically feasible
for a small supplier to maintain a storefront.
Response: We do not require that a DMEPOS supplier maintain a
storefront, and if the DMEPOS supplier chooses to maintain a
storefront, it may be coupled with its storage space for DMEPOS.
However, if the supplier is in a commercial building, the sign can be
posted at the entrance of the building. We believe that it is essential
for our beneficiaries and site reviewers to be able to promptly locate
the supplier. Therefore, the signage must be readily visible to the
general public. We understand the concerns that additional costs may be
incurred for small businesses. However we believe that the majority of
our DMEPOS suppliers already meet this requirement. Additionally, those
DMEPOS suppliers with less than the 200 square foot minimum space and
who have entered into a long term lease before the publication of this
final rule will have time to transition into a new location, as
explained later in this rule.
Comment: Several commenters stated that they do not support CMS'
proposal to micromanage a supplier's business operation by dictating
size, hours, staffing, and access via a single standard without
exception for the specific services being furnished.
Response: We believe that the provisions of Sec. 424.57(c)(7) are
designed to ensure that DMEPOS suppliers conform to generally accepted
business practices employed by quality suppliers.
Comment: Several commenters believe it would be in CMS's best
interest to retain the current policy which allows for a central record
storage location for multi-State DME suppliers.
Response: We agree that multistate DME suppliers can maintain
central record storage locations and have amended the regulations text
in Sec. 424.57(c)(7)(i) to reflect this concern.
Comment: One commenter stated that there can be a problem with the
requirement of external signage when it conflicts with local zoning
ordinances.
Response: We believe that prospective suppliers of DMEPOS and
existing suppliers of DMEPOS must understand and comply with the
supplier standards found in this section. Accordingly, prospective
suppliers of DMEPOS should ensure that their practice location meets
the requirements found in Sec. 424.57(c)(7) and the other supplier
standards found in this section prior to buying or entering into a
leasing arrangement for a given practice location. For example, if the
owner of prospective supplier of DMEPOS knows or should have known that
local zoning ordinances preclude the establishment of home-business in
a residential neighborhood, then the prospective supplier of DMEPOS
should make the business decision to: (1) Obtain a waiver to the local
zoning ordinance in advance of submitting their enrollment application
to the NSC; or (2) select a different practice location that will
ensure the supplier's compliance with the requirements specified in
Sec. 424.57(c)(7).
Comment: One commenter stated that it may not be possible to
fulfill the signage requirement because the owner of the building may
not allow the posting of the sign, and that the patients that they see
are by appointment only so posting a sign with office hours is not
necessary.
Response: As previously stated, we believe that prospective
suppliers of DMEPOS and existing suppliers of DMEPOS must understand
and comply with the supplier standards found in this section.
Accordingly, prospective suppliers of DMEPOS should ensure that their
practice location meets the requirements found in Sec. 424.57(c)(7)
and the other supplier standards found in this section prior to buying
or entering into a leasing arrangement for a given practice location.
Accordingly,
[[Page 52636]]
we disagree with this commenter, and believe that it is essential that
the beneficiaries and CMS agents can clearly see where the supplier is
located and the supplier's hours of operation. If the building owner
will not allow the posting of hours of operation, then the DMEPOS
supplier should consider the supplier site to be inappropriate for a
business that serves Medicare beneficiaries. Even for suppliers that
take appointments, we believe that proper signage and posted hours are
required for proper beneficiary information.
Comment: One commenter believes it is not always possible to give
the NSC prior notice to a change in the hours of operation.
Response: While we understand that suppliers have 30 days to notify
the NSC of change in posted business hours, we do not believe that
legitimate suppliers routinely change their posted hours of operation
frequently. Moreover, there is nothing in our current rules or within
this final regulation which precludes a DMEPOS supplier from notifying
the NSC prior to or at the time a change of posted business hours are
implemented.
Comment: A commenter stated that size and space requirements are
already established in the accreditation process, and therefore, are
unnecessary as a separate supplier standard.
Response: Since the requirements included within accreditation
standards set forth in Sec. 424.57(c)(21) through Sec. 424.57(c)(25)
and quality standards are independent of the supplier standards in
Sec. 424.57, we believe that it is appropriate to establish a minimum
square footage requirement to assist us in determining whether a DMEPOS
supplier is operating a legitimate business as neither of the
aforementioned sets of standards include a provision for minimum square
footage.
Comment: One commenter requested what defines a permanent, durable
sign and noted that sometimes it may be necessary to have permanent
signage attached to the glass panel of a facility.
Response: While we have not defined what constitutes a permanent
durable sign, there is no requirement that a permanent sign be or not
be attached to a glass panel.
Comment: Several commenters suggested that an exemption should be
granted when it is necessary for the office to be temporarily closed
during posted office hours to account for holidays, natural disasters,
short-term closures, patient deliveries, emergencies, and other
unforeseen occurrences.
Response: We note that we have always made exceptions concerning
posted hours for disasters and emergencies and Federal and State
holidays. However, while we recognize that personal emergencies do
occur, we believe that suppliers should be available during posted
business hours. Moreover, we believe that a DMEPOS supplier should do
its best to plan and staff for temporary absences.
Comment: One commenter believes the minimum square footage
requirement causes potential issues for orthotic and prosthetic
suppliers since the lab area is separate from the patient area and is
often located off-site. The patient interaction area is most important,
but since this area can be as small as 80 square feet, the size
requirement should not be imposed as to orthotic and prosthetic
suppliers.
Response: We agree with the concerns raised by this commenter and
have adopted an exception to Sec. 424.57(c)(7) for State-licensed
orthotic and prosthetic personnel in private practice as one of the
exceptions to this provision.
Comment: One commenter suggests that rather than mandating a
certain amount of square footage, an alternative could be a rule
indicating that the office space must consist of an ADA accessible
reception area, a minimum of one examination room and a restroom,
unless there is a common area restroom.
Response: We believe that it would be very difficult for us to
develop specifications for these items. Moreover, we believe that doing
so would likely be more restrictive for some types of suppliers.
Comment: One commenter notes that in most leased spaces, especially
in medical buildings, the signage locations are predetermined, and
therefore, the commenters do not believe a quality standard should
mandate signage on the exterior of the building.
Response: We believe that the sign must be visible at the main
entrance of the facility and visible to the public. Therefore, in a
public medical building, the sign could be posted in the main lobby
entrance if access to the lobby is available to the general public.
Comment: One commenter recommended that if CMS does set minimum
square footage requirements that we give suppliers time for the
expiration of current leases and to obtain a new location or
``grandfather'' locations already in use.
Response: We agree with this commenter and will establish a 3-year
phase-in period for those existing suppliers of DMEPOS who have signed
leases, including long-term leases, on or before the publication date
of this final rule. We believe that this phase-in period will provide
small businesses with sufficient time to identify a practice location
that meets the minimum square footage requirement. We will make this
requirement effective for existing DMEPOS suppliers 3 years from the
effective date of this regulation. However, we do not believe that it
is appropriate to establish a similar requirement for prospective
suppliers of DMEPOS, including those suppliers who have a pending
enrollment application with the NSC. Consequently, we expect
prospective DMEPOS suppliers to comply with this requirement as of the
effective date of this regulation. As prospective DMEPOS suppliers seek
billing privileges after the effective date of this regulation, we
expect them to comply with this requirement in order to be enrolled in
Medicare.
Comment: One commenter is concerned that the minimum square footage
requirement may be over interpreted as a means to shut down legitimate
suppliers (for example, a legitimate supplier being 25 feet short after
the rule becomes effective but having a 5-year lease to fulfill).
Response: We proposed the minimum square footage as a basis for
ensuring that legitimate suppliers are meeting the supplier standards
in Sec. 424.57 and that these suppliers are providing quality products
and services to Medicare beneficiaries. As stated previously, we will
impose this requirement on those suppliers who have entered into
leases, including long-term leases, on or before the date of
publication of this final rule. Accordingly, we maintain that DMEPOS
suppliers who had entered into lease arrangements of 1 year or less
must come into compliance with this provision at the end of their
current lease. Similarly, DMEPOS suppliers who have entered into
leasing arrangements of more than 1 year but less than 3 years must
come into compliance with this standard at the end of their current
lease; and that all existing DMEPOS suppliers must come into compliance
with this standard within 3 years of the effective date of this final
rule.
Finally, while we are establishing a transition period for
implementation of this requirement for DMEPOS suppliers already
enrolled in the Medicare program, we are not adopting a transition
period for DMEPOS suppliers enrolling a new practice location,
reactivating the billing privileges for a DMEPOS supplier previously
enrolled in the Medicare program or for DMEPOS suppliers changing their
existing
[[Page 52637]]
practice location or selling their existing practice location.
Comment: One commenter notes that licensing and accrediting bodies
inspect suppliers' facilities to assure the supplier has a legally
defined means of providing care. The commenter believes that Medicare
should have no role in determining the appropriateness of a supplier's
facility.
Response: While we agree that licensing and accreditation are
essential elements for ensuring quality of care, we disagree with the
commenter that CMS or our designated contractor should have no role in
determining the appropriateness of a supplier's facility. Since the
implementation of the DMEPOS supplier standards in October of 2000, we
have played an important role in determining the appropriateness of a
supplier's facility via regulation at Sec. 424.57.
Comment: One commenter questioned why the square footage matters if
a supplier meets all requirements and has Medicare beneficiaries coming
to the supplier's physical location where products are stocked and
provided.
Response: We maintain that an appropriate amount of square footage
is generally necessary to ensure that the facility can meet its
obligations to a beneficiary which include an area for the beneficiary
to sit, or room for a wheelchair and room for it to turn/move around,
as well as room for stock and for the equipment necessary for running a
business. In addition, in the past many suppliers with very minimal
square footage have been determined to be fraudulent or have provided
inferior service to Medicare beneficiaries.
Comment: One commenter questioned whether it is CMS' intent to
require suppliers to be a retail-type business by mandating minimum
square footage which needlessly drives up the cost of doing business
for nonretail suppliers.
Response: While ``closed door'' businesses are eligible to
participate in the Medicare program, we believe that it is necessary to
include a minimum square footage into what is considered an appropriate
site. We understand there may be concern that this requirement may
cause a change in business practices for smaller suppliers and could
possibly result in increased costs. However, we believe that most
DMEPOS suppliers are already meeting this standard.
Comment: A commenter stated that the minimum square footage
requirement is not appropriate because the Federal rule would preempt
State or local land use or supplier laws already in place and will not
take into account the supplier's operations or the needs of the
beneficiaries being serviced.
Response: We disagree with this commenter. While we are not
preempting State and local land use laws, we are establishing criteria
to enroll in the Medicare program as a DMEPOS supplier. We believe that
this revised criterion will help to ensure that Medicare beneficiaries
receive quality services from quality suppliers.
Comment: A commenter stated that the minimum square footage
requirement is unnecessary for suppliers' facilities that are not
intended for beneficiary access and that this proposed standard blurs
the distinction between a classic retail establishment and a service
facility dedicated to the provision of supplies and equipment to
patients in their homes. In addition, the commenter requests that CMS
consider different business models for supplier standards, including
suppliers that provide quality items and services to beneficiaries, but
do not operate facilities intended to be stores for in-person access.
Response: We disagree with this commenter. Since most DMEPOS
suppliers are not solely service facilities, we believe that these
enrolled suppliers must provide reasonable access for Medicare
beneficiaries in the event that a beneficiary has a problem or requires
prompt service. It is also essential that CMS or our agents have access
during posted hours of operations to ensure that the supplier continues
to meet the supplier standards in Sec. 424.57.
Comment: A commenter suggests that CMS consider that the
appropriate size of a facility is based on the services provided, the
size of the organization and the status of the location.
Response: We appreciate this comment and have considered these
factors in adopting a minimum square footage requirement for DMEPOS
suppliers. As noted previously, we maintain that an appropriate amount
of square footage is generally necessary to ensure that the facility
can meet its obligations to a beneficiary